User login
Continuing Medical Education Program in
If you wish to receive credit for this activity, which beginson the next page, please refer to the website:
Accreditation and Designation Statement
Blackwell Futura Media Services designates this educational activity for a 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Educational Objectives
Upon completion of this educational activity, participants will be better able to:
-
Identify the approximate 30‐day readmission rate of Medicare patient hospitalized initially for pneumonia.
-
Distinguish which variables were accounted and unaccounted for in the development of a pneumonia readmission model.
Continuous participation in the Journal of Hospital Medicine CME program will enable learners to be better able to:
-
Interpret clinical guidelines and their applications for higher quality and more efficient care for all hospitalized patients.
-
Describe the standard of care for common illnesses and conditions treated in the hospital; such as pneumonia, COPD exacerbation, acute coronary syndrome, HF exacerbation, glycemic control, venous thromboembolic disease, stroke, etc.
-
Discuss evidence‐based recommendations involving transitions of care, including the hospital discharge process.
-
Gain insights into the roles of hospitalists as medical educators, researchers, medical ethicists, palliative care providers, and hospital‐based geriatricians.
-
Incorporate best practices for hospitalist administration, including quality improvement, patient safety, practice management, leadership, and demonstrating hospitalist value.
-
Identify evidence‐based best practices and trends for both adult and pediatric hospital medicine.
Instructions on Receiving Credit
For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period that is noted on the title page.
Follow these steps to earn credit:
-
Log on to
www.blackwellpublishing.com/cme . -
Read the target audience, learning objectives, and author disclosures.
-
Read the article in print or online format.
-
Reflect on the article.
-
Access the CME Exam, and choose the best answer to each question.
-
Complete the required evaluation component of the activity.
If you wish to receive credit for this activity, which beginson the next page, please refer to the website:
Accreditation and Designation Statement
Blackwell Futura Media Services designates this educational activity for a 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Educational Objectives
Upon completion of this educational activity, participants will be better able to:
-
Identify the approximate 30‐day readmission rate of Medicare patient hospitalized initially for pneumonia.
-
Distinguish which variables were accounted and unaccounted for in the development of a pneumonia readmission model.
Continuous participation in the Journal of Hospital Medicine CME program will enable learners to be better able to:
-
Interpret clinical guidelines and their applications for higher quality and more efficient care for all hospitalized patients.
-
Describe the standard of care for common illnesses and conditions treated in the hospital; such as pneumonia, COPD exacerbation, acute coronary syndrome, HF exacerbation, glycemic control, venous thromboembolic disease, stroke, etc.
-
Discuss evidence‐based recommendations involving transitions of care, including the hospital discharge process.
-
Gain insights into the roles of hospitalists as medical educators, researchers, medical ethicists, palliative care providers, and hospital‐based geriatricians.
-
Incorporate best practices for hospitalist administration, including quality improvement, patient safety, practice management, leadership, and demonstrating hospitalist value.
-
Identify evidence‐based best practices and trends for both adult and pediatric hospital medicine.
Instructions on Receiving Credit
For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period that is noted on the title page.
Follow these steps to earn credit:
-
Log on to
www.blackwellpublishing.com/cme . -
Read the target audience, learning objectives, and author disclosures.
-
Read the article in print or online format.
-
Reflect on the article.
-
Access the CME Exam, and choose the best answer to each question.
-
Complete the required evaluation component of the activity.
If you wish to receive credit for this activity, which beginson the next page, please refer to the website:
Accreditation and Designation Statement
Blackwell Futura Media Services designates this educational activity for a 1 AMA PRA Category 1 Credit. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Blackwell Futura Media Services is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Educational Objectives
Upon completion of this educational activity, participants will be better able to:
-
Identify the approximate 30‐day readmission rate of Medicare patient hospitalized initially for pneumonia.
-
Distinguish which variables were accounted and unaccounted for in the development of a pneumonia readmission model.
Continuous participation in the Journal of Hospital Medicine CME program will enable learners to be better able to:
-
Interpret clinical guidelines and their applications for higher quality and more efficient care for all hospitalized patients.
-
Describe the standard of care for common illnesses and conditions treated in the hospital; such as pneumonia, COPD exacerbation, acute coronary syndrome, HF exacerbation, glycemic control, venous thromboembolic disease, stroke, etc.
-
Discuss evidence‐based recommendations involving transitions of care, including the hospital discharge process.
-
Gain insights into the roles of hospitalists as medical educators, researchers, medical ethicists, palliative care providers, and hospital‐based geriatricians.
-
Incorporate best practices for hospitalist administration, including quality improvement, patient safety, practice management, leadership, and demonstrating hospitalist value.
-
Identify evidence‐based best practices and trends for both adult and pediatric hospital medicine.
Instructions on Receiving Credit
For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity during the valid credit period that is noted on the title page.
Follow these steps to earn credit:
-
Log on to
www.blackwellpublishing.com/cme . -
Read the target audience, learning objectives, and author disclosures.
-
Read the article in print or online format.
-
Reflect on the article.
-
Access the CME Exam, and choose the best answer to each question.
-
Complete the required evaluation component of the activity.
Pneumonia Readmission Validation
Hospital readmissions are emblematic of the numerous challenges facing the US health care system. Despite high levels of spending, nearly 20% of Medicare beneficiaries are readmitted within 30 days of hospital discharge, many readmissions are considered preventable, and rates vary widely by hospital and region.1 Further, while readmissions have been estimated to cost taxpayers as much as $17 billion annually, the current fee‐for‐service method of paying for the acute care needs of seniors rewards hospitals financially for readmission, not their prevention.2
Pneumonia is the second most common reason for hospitalization among Medicare beneficiaries, accounting for approximately 650,000 admissions annually,3 and has been a focus of national quality‐improvement efforts for more than a decade.4, 5 Despite improvements in key processes of care, rates of readmission within 30 days of discharge following a hospitalization for pneumonia have been reported to vary from 10% to 24%.68 Among several factors, readmissions are believed to be influenced by the quality of both inpatient and outpatient care, and by care‐coordination activities occurring in the transition from inpatient to outpatient status.912
Public reporting of hospital performance is considered a key strategy for improving quality, reducing costs, and increasing the value of hospital care, both in the US and worldwide.13 In 2009, the Centers for Medicare & Medicaid Services (CMS) expanded its reporting initiatives by adding risk‐adjusted hospital readmission rates for acute myocardial infarction, heart failure, and pneumonia to the Hospital Compare website.14, 15 Readmission rates are an attractive focus for public reporting for several reasons. First, in contrast to most process‐based measures of quality (eg, whether a patient with pneumonia received a particular antibiotic), a readmission is an adverse outcome that matters to patients and families.16 Second, unlike process measures whose assessment requires detailed review of medical records, readmissions can be easily determined from standard hospital claims. Finally, readmissions are costly, and their prevention could yield substantial savings to society.
A necessary prerequisite for public reporting of readmission is a validated, risk‐adjusted measure that can be used to track performance over time and can facilitate comparisons across institutions. Toward this end, we describe the development, validation, and results of a National Quality Forum‐approved and CMS‐adopted model to estimate hospital‐specific, risk‐standardized, 30‐day readmission rates for Medicare patients hospitalized with pneumonia.17
METHODS
Data Sources
We used 20052006 claims data from Medicare inpatient, outpatient, and carrier (physician) Standard Analytic Files to develop and validate the administrative model. The Medicare Enrollment Database was used to determine Medicare fee‐for‐service enrollment and mortality statuses. A medical record model, used for additional validation of the administrative model, was developed using information abstracted from the charts of 75,616 pneumonia cases from 19982001 as part of the National Pneumonia Project, a CMS quality improvement initiative.18
Study Cohort
We identified hospitalizations of patients 65 years of age and older with a principal diagnosis of pneumonia (International Classification of Diseases, 9th Revision, Clinical Modification codes 480.XX, 481, 482.XX, 483.X, 485, 486, 487.0) as potential index pneumonia admissions. Because our focus was readmission for patients discharged from acute care settings, we excluded admissions in which patients died or were transferred to another acute care facility. Additionally, we restricted analysis to patients who had been enrolled in fee‐for‐service Medicare Parts A and B, for at least 12 months prior to their pneumonia hospitalization, so that we could use diagnostic codes from all inpatient and outpatient encounters during that period to enhance identification of comorbidities.
Outcome
The outcome was 30‐day readmission, defined as occurrence of at least one hospitalization for any cause within 30 days of discharge after an index admission. Readmissions were identified from hospital claims data, and were attributed to the hospital that had discharged the patient. A 30‐day time frame was selected because it is a clinically meaningful period during which hospitals can be expected to collaborate with other organizations and providers to implement measures to reduce the risk of rehospitalization.
Candidate and Final Model Variables
Candidate variables for the administrative claims model were selected by a clinician team from 189 diagnostic groups included in the Hierarchical Condition Category (HCC) clinical classification system.19 The HCC clinical classification system was developed for CMS in preparation for all‐encounter risk adjustment for Medicare Advantage (managed care). Under the HCC algorithm, the 15,000+ ICD‐9‐CM diagnosis codes are assigned to one of 189 clinically‐coherent condition categories (CCs). We used the April 2008 version of the ICD‐9‐CM to CC assignment map, which is maintained by CMS and posted at
The final risk‐adjustment model included 39 variables selected by the team of clinicians and analysts, primarily based on their clinical relevance but also with knowledge of the strength of their statistical association with readmission outcome (Table 1). For each patient, the presence or absence of these conditions was assessed from multiple sources, including secondary diagnoses during the index admission, principal and secondary diagnoses from hospital admissions in the 12 months prior to the index admission, and diagnoses from hospital outpatient and physician encounters 12 months before the index admission. A small number of CCs were considered to represent potential complications of care (eg, bleeding). Because we did not want to adjust for complications of care occurring during the index admission, a patient was not considered to have one of these conditions unless it was also present in at least one encounter prior to the index admission.
Variable | Frequencies | Estimate | Standard Error | Odds Ratio | 95% CI | |
---|---|---|---|---|---|---|
| ||||||
Intercept | 2.395 | 0.021 | ||||
Age 65 (years above 65, continuous) | 0.0001 | 0.001 | 1.000 | 0.998 | 1.001 | |
Male | 45 | 0.071 | 0.012 | 1.073 | 1.048 | 1.099 |
History of CABG | 5.2 | 0.179 | 0.027 | 0.836 | 0.793 | 0.881 |
Metastatic cancer and acute leukemia (CC 7) | 4.3 | 0.177 | 0.029 | 1.194 | 1.128 | 1.263 |
Lung, upper digestive tract, and other severe cancers (CC 8) | 6.0 | 0.256 | 0.024 | 1.292 | 1.232 | 1.354 |
Diabetes and DM complications (CC 15‐20, 119, 120) | 36 | 0.059 | 0.012 | 1.061 | 1.036 | 1.087 |
Disorders of fluid/electrolyte/acid‐base (CC 22, 23) | 34 | 0.149 | 0.013 | 1.160 | 1.131 | 1.191 |
Iron deficiency and other/unspecified anemias and blood disease (CC 47) | 46 | 0.118 | 0.012 | 1.126 | 1.099 | 1.153 |
Other psychiatric disorders (CC 60) | 12 | 0.108 | 0.017 | 1.114 | 1.077 | 1.151 |
Cardio‐respiratory failure and shock (CC 79) | 16 | 0.114 | 0.016 | 1.121 | 1.087 | 1.156 |
Congestive heart failure (CC 80) | 39 | 0.151 | 0.014 | 1.163 | 1.133 | 1.194 |
Chronic atherosclerosis (CC 83, 84) | 47 | 0.051 | 0.013 | 1.053 | 1.027 | 1.079 |
Valvular and rheumatic heart disease (CC 86) | 23 | 0.062 | 0.014 | 1.064 | 1.036 | 1.093 |
Arrhythmias (CC 92, 93) | 38 | 0.126 | 0.013 | 1.134 | 1.107 | 1.163 |
Vascular or circulatory disease (CC 104‐106) | 38 | 0.088 | 0.012 | 1.092 | 1.066 | 1.119 |
COPD (CC 108) | 58 | 0.186 | 0.013 | 1.205 | 1.175 | 1.235 |
Fibrosis of lung and other chronic lung disorders (CC 109) | 17 | 0.086 | 0.015 | 1.090 | 1.059 | 1.122 |
Renal failure (CC 131) | 17 | 0.147 | 0.016 | 1.158 | 1.122 | 1.196 |
Protein‐calorie malnutrition (CC 21) | 7.9 | 0.121 | 0.020 | 1.129 | 1.086 | 1.173 |
History of infection (CC 1, 3‐6) | 35 | 0.068 | 0.012 | 1.071 | 1.045 | 1.097 |
Severe hematological disorders (CC 44) | 3.6 | 0.117 | 0.028 | 1.125 | 1.064 | 1.188 |
Decubitus ulcer or chronic skin ulcer (CC 148, 149) | 10 | 0.101 | 0.018 | 1.106 | 1.067 | 1.146 |
History of pneumonia (CC 111‐113) | 44 | 0.065 | 0.013 | 1.067 | 1.041 | 1.094 |
Vertebral fractures (CC 157) | 5.1 | 0.113 | 0.024 | 1.120 | 1.068 | 1.174 |
Other injuries (CC 162) | 32 | 0.061 | 0.012 | 1.063 | 1.038 | 1.089 |
Urinary tract infection (CC 135) | 26 | 0.064 | 0.014 | 1.066 | 1.038 | 1.095 |
Lymphatic, head and neck, brain, and other major cancers; breast, prostate, colorectal, and other cancers and tumors (CC 9‐10) | 16 | 0.050 | 0.016 | 1.051 | 1.018 | 1.084 |
End‐stage renal disease or dialysis (CC 129, 130) | 1.9 | 0.131 | 0.037 | 1.140 | 1.060 | 1.226 |
Drug/alcohol abuse/dependence/psychosis (CC 51‐53) | 12 | 0.081 | 0.017 | 1.084 | 1.048 | 1.121 |
Septicemia/shock (CC 2) | 6.3 | 0.094 | 0.022 | 1.098 | 1.052 | 1.146 |
Other gastrointestinal disorders (CC 36) | 56 | 0.073 | 0.012 | 1.076 | 1.051 | 1.102 |
Acute coronary syndrome (CC 81, 82) | 8.3 | 0.126 | 0.019 | 1.134 | 1.092 | 1.178 |
Pleural effusion/pneumothorax (CC 114) | 12 | 0.083 | 0.017 | 1.086 | 1.051 | 1.123 |
Other urinary tract disorders (CC 136) | 24 | 0.059 | 0.014 | 1.061 | 1.033 | 1.090 |
Stroke (CC 95, 96) | 10 | 0.047 | 0.019 | 1.049 | 1.011 | 1.088 |
Dementia and senility (CC 49, 50) | 27 | 0.031 | 0.014 | 1.031 | 1.004 | 1.059 |
Hemiplegia, paraplegia, paralysis, functional disability (CC 67‐69, 100‐102, 177, 178) | 7.4 | 0.068 | 0.021 | 1.070 | 1.026 | 1.116 |
Other lung disorders (CC 115) | 45 | 0.005 | 0.012 | 1.005 | 0.982 | 1.030 |
Major psychiatric disorders (CC 54‐56) | 11 | 0.038 | 0.018 | 1.038 | 1.003 | 1.075 |
Asthma (CC 110) | 12 | 0.006 | 0.018 | 1.006 | 0.972 | 1.041 |
Model Derivation
For the development of the administrative claims model, we randomly sampled half of 2006 hospitalizations that met inclusion criteria. To assess model performance at the patient level, we calculated the area under the receiver operating curve (AUC), and calculated observed readmission rates in the lowest and highest deciles on the basis of predicted readmission probabilities. We also compared performance with a null model, a model that adjusted for age and sex, and a model that included all candidate variables.20
Risk‐Standardized Readmission Rates
Using hierarchical logistic regression, we modeled the log‐odds of readmission within 30 days of discharge from an index pneumonia admission as a function of patient demographic and clinical characteristics, and a random hospital‐specific intercept. This strategy accounts for within‐hospital correlation, or clustering, of observed outcomes, and models the assumption that underlying differences in quality among hospitals being evaluated lead to systematic differences in outcomes. We then calculated hospital‐specific readmission rates as the ratio of predicted‐to‐expected readmissions (similar to observed/expected ratio), multiplied by the national unadjusted ratea form of indirect standardization. Predicted number of readmissions in each hospital is estimated given the same patient mix and its estimated hospital‐specific intercept. Expected number of readmissions in each hospital is estimated using its patient mix and the average hospital‐specific intercept. To assess hospital performance in any given year, we re‐estimate model coefficients using that year's data.
Model Validation: Administrative Claims
We compared the model performance in the development sample with its performance in the sample from the 2006 data that was not selected for the development set, and separately among pneumonia admissions in 2005. The model was recalibrated in each validation set.
Model Validation: Medical Record Abstraction
We developed a separate medical record‐based model of readmission risk using information from charts that had previously been abstracted as part of CMS's National Pneumonia Project. To select variables for this model, the clinician team: 1) reviewed the list of variables that were included in a medical record model that was previously developed for validating the National Quality Forum‐approved pneumonia mortality measure; 2) reviewed a list of other potential candidate variables available in the National Pneumonia Project dataset; and 3) reviewed variables that emerged as potentially important predictors of readmission, based on a systematic review of the literature that was conducted as part of measure development. This selection process resulted in a final medical record model that included 35 variables.
We linked patients in the National Pneumonia Project cohort to their Medicare claims data, including claims from one year before the index hospitalization, so that we could calculate risk‐standardized readmission rates in this cohort separately using medical record and claims‐based models. This analysis was conducted at the state level, for the 50 states plus the District of Columbia and Puerto Rico, because medical record data were unavailable in sufficient numbers to permit hospital‐level comparisons. To examine the relationship between risk‐standardized rates obtained from medical record and administrative data models, we estimated a linear regression model describing the association between the two rates, weighting each state by number of index hospitalizations, and calculated the correlation coefficient and the intercept and slope of this equation. A slope close to 1 and an intercept close to 0 would provide evidence that risk‐standardized state readmission rates from the medical record and claims models were similar. We also calculated the difference between state risk‐standardized readmission rates from the two models.
Analyses were conducted with the use of SAS version 9.1.3 (SAS Institute Inc, Cary, NC). Models were fitted separately for the National Pneumonia Project and 2006 cohort. We estimated the hierarchical models using the GLIMMIX procedure in SAS. The Human Investigation Committee at the Yale School of Medicine approved an exemption for the authors to use CMS claims and enrollment data for research analyses and publication.
RESULTS
Model Derivation and Performance
After exclusions were applied, the 2006 sample included 453,251 pneumonia hospitalizations (Figure 1). The development sample consisted of 226,545 hospitalizations at 4675 hospitals, with an overall unadjusted 30‐day readmission rate of 17.4%. In 11,694 index cases (5.2%), the patient died within 30 days without being readmitted. Median readmission rate was 16.3%, 25th and 75th percentile rates were 11.1% and 21.3%, and at the 10th and 90th percentile, hospital readmission rates ranged from 4.6% to 26.7% (Figure 2).
The claims model included 39 variables (age, sex, and 37 clinical variables) (Table 1). The mean age of the cohort was 80.0 years, with 55.5% women and 11.1% nonwhite patients. Mean observed readmission rate in the development sample ranged from 9% in the lowest decile of predicted pneumonia readmission rates to 32% in the highest predicted decile, a range of 23%. The AUC was 0.63. For comparison, a model with only age and sex had an AUC of 0.51, and a model with all candidate variables had an AUC equal to 0.63 (Table 2).
Calibration (0, 1)* | Discrimination | Residuals Lack of Fit (Pearson Residual Fall %) | Model 2 (No. of Covariates) | ||||||
---|---|---|---|---|---|---|---|---|---|
Predictive Ability (Lowest Decile, Highest Decile) | AUC | (<2) | (2, 0) | (0, 2) | (2+) | ||||
| |||||||||
Development sample | |||||||||
2006 | (1st half) N = 226,545 | (0, 1) | (0.09, 0.32) | 0.63 | 0 | 82.62 | 7.39 | 9.99 | 6,843 (40) |
Validation sample | |||||||||
2006 | (2nd half) N = 226,706 | (0.002, 0.997) | (0.09, 0.31) | 0.63 | 0 | 82.55 | 7.45 | 9.99 | 6,870 (40) |
2005 | N = 536,015 | (0.035, 1.008) | (0.08, 0.31) | 0.63 | 0 | 82.67 | 7.31 | 10.03 | 16,241 (40) |
Hospital Risk‐Standardized Readmission Rates
Risk‐standardized readmission rates varied across hospitals (Figure 3). Median risk‐standardized readmission rate was 17.3%, and the 25th and 75th percentiles were 16.9% and 17.9%, respectively. The 5th percentile was 16.0% and the 95th percentile was 19.1%. Odds of readmission for a hospital one standard deviation above average was 1.4 times that of a hospital one standard deviation below average.
Administrative Model Validation
In the remaining 50% of pneumonia index hospitalizations from 2006, and the entire 2005 cohort, regression coefficients and standard errors of model variables were similar to those in the development data set. Model performance using 2005 data was consistent with model performance using the 2006 development and validation half‐samples (Table 2).
Medical Record Validation
After exclusions, the medical record sample taken from the National Pneumonia Project included 47,429 cases, with an unadjusted 30‐day readmission rate of 17.0%. The final medical record risk‐adjustment model included a total of 35 variables, whose prevalence and association with readmission risk varied modestly (Table 3). Performance of the medical record and administrative models was similar (areas under the ROC curve 0.59 and 0.63, respectively) (Table 4). Additionally, in the administrative model, predicted readmission rates ranged from 8% in the lowest predicted decile to 30% in the highest predicted decile, while in the medical record model, the corresponding rates varied from 10% to 26%.
Variable | Percent | Estimate | Standard Error | Odds Ratio | 95% CI | |
---|---|---|---|---|---|---|
| ||||||
Age 65, mean (SD) | 15.24 (7.87) | 0.003 | 0.002 | 0.997 | 0.993 | 1.000 |
Male | 46.18 | 0.122 | 0.025 | 1.130 | 1.075 | 1.188 |
Nursing home resident | 17.71 | 0.035 | 0.037 | 1.036 | 0.963 | 1.114 |
Neoplastic disease | 6.80 | 0.130 | 0.049 | 1.139 | 1.034 | 1.254 |
Liver disease | 1.04 | 0.089 | 0.123 | 0.915 | 0.719 | 1.164 |
History of heart failure | 28.98 | 0.234 | 0.029 | 1.264 | 1.194 | 1.339 |
History of renal disease | 8.51 | 0.188 | 0.047 | 1.206 | 1.100 | 1.323 |
Altered mental status | 17.95 | 0.009 | 0.034 | 1.009 | 0.944 | 1.080 |
Pleural effusion | 21.20 | 0.165 | 0.030 | 1.179 | 1.111 | 1.251 |
BUN 30 mg/dl | 23.28 | 0.160 | 0.033 | 1.174 | 1.100 | 1.252 |
BUN missing | 14.56 | 0.101 | 0.185 | 0.904 | 0.630 | 1.298 |
Systolic BP <90 mmHg | 2.95 | 0.068 | 0.070 | 1.070 | 0.932 | 1.228 |
Systolic BP missing | 11.21 | 0.149 | 0.425 | 1.160 | 0.504 | 2.669 |
Pulse 125/min | 7.73 | 0.036 | 0.047 | 1.036 | 0.945 | 1.137 |
Pulse missing | 11.22 | 0.210 | 0.405 | 1.234 | 0.558 | 2.729 |
Respiratory rate 30/min | 16.38 | 0.079 | 0.034 | 1.082 | 1.012 | 1.157 |
Respiratory rate missing | 11.39 | 0.204 | 0.240 | 1.226 | 0.765 | 1.964 |
Sodium <130 mmol/L | 4.82 | 0.136 | 0.057 | 1.145 | 1.025 | 1.280 |
Sodium missing | 14.39 | 0.049 | 0.143 | 1.050 | 0.793 | 1.391 |
Glucose 250 mg/dl | 5.19 | 0.005 | 0.057 | 0.995 | 0.889 | 1.114 |
Glucose missing | 15.44 | 0.156 | 0.105 | 0.855 | 0.696 | 1.051 |
Hematocrit <30% | 7.77 | 0.270 | 0.044 | 1.310 | 1.202 | 1.428 |
Hematocrit missing | 13.62 | 0.071 | 0.135 | 0.932 | 0.715 | 1.215 |
Creatinine 2.5 mg/dL | 4.68 | 0.109 | 0.062 | 1.115 | 0.989 | 1.258 |
Creatinine missing | 14.63 | 0.200 | 0.167 | 1.221 | 0.880 | 1.695 |
WBC 6‐12 b/L | 38.04 | 0.021 | 0.049 | 0.979 | 0.889 | 1.079 |
WBC >12 b/L | 41.45 | 0.068 | 0.049 | 0.934 | 0.848 | 1.029 |
WBC missing | 12.85 | 0.167 | 0.162 | 1.181 | 0.860 | 1.623 |
Immunosuppressive therapy | 15.01 | 0.347 | 0.035 | 1.415 | 1.321 | 1.516 |
Chronic lung disease | 42.16 | 0.137 | 0.028 | 1.147 | 1.086 | 1.211 |
Coronary artery disease | 39.57 | 0.150 | 0.028 | 1.162 | 1.100 | 1.227 |
Diabetes mellitus | 20.90 | 0.137 | 0.033 | 1.147 | 1.076 | 1.223 |
Alcohol/drug abuse | 3.40 | 0.099 | 0.071 | 0.906 | 0.788 | 1.041 |
Dementia/Alzheimer's disease | 16.38 | 0.125 | 0.038 | 1.133 | 1.052 | 1.222 |
Splenectomy | 0.44 | 0.016 | 0.186 | 1.016 | 0.706 | 1.463 |
Model | Calibration (0, 1)* | Discrimination | Residuals Lack of Fit (Pearson Residual Fall %) | Model 2 (No. of Covariates) | ||||
---|---|---|---|---|---|---|---|---|
Predictive Ability (Lowest Decile, Highest Decile) | AUC | (<2) | (2, 0) | (0, 2) | (2+) | |||
| ||||||||
Medical Record Model Development Sample (NP) | ||||||||
N = 47,429 No. of 30‐day readmissions = 8,042 | (1, 0) | (0.10, 0.26) | 0.59 | 0 | 83.04 | 5.28 | 11.68 | 710 (35) |
Linked Administrative Model Validation Sample | ||||||||
N = 47,429 No. of 30‐day readmissions = 8,042 | (1, 0) | (0.08, 0.30) | 0.63 | 0 | 83.04 | 6.94 | 10.01 | 1,414 (40) |
The correlation coefficient of the estimated state‐specific standardized readmission rates from the administrative and medical record models was 0.96, and the proportion of the variance explained by the model was 0.92 (Figure 4).
DISCUSSION
We have described the development, validation, and results of a hospital, 30‐day, risk‐standardized readmission model for pneumonia that was created to support current federal transparency initiatives. The model uses administrative claims data from Medicare fee‐for‐service patients and produces results that are comparable to a model based on information obtained through manual abstraction of medical records. We observed an overall 30‐day readmission rate of 17%, and our analyses revealed substantial variation across US hospitals, suggesting that improvement by lower performing institutions is an achievable goal.
Because more than one in six pneumonia patients are rehospitalized shortly after discharge, and because pneumonia hospitalizations represent an enormous expense to the Medicare program, prevention of readmissions is now widely recognized to offer a substantial opportunity to improve patient outcomes while simultaneously lowering health care costs. Accordingly, promotion of strategies to reduce readmission rates has become a key priority for payers and quality‐improvement organizations. These range from policy‐level attempts to stimulate change, such as publicly reporting hospital readmission rates on government websites, to establishing accreditation standardssuch as the Joint Commission's requirement to accurately reconcile medications, to the creation of quality improvement collaboratives focused on sharing best practices across institutions. Regardless of the approach taken, a valid, risk‐adjusted measure of performance is required to evaluate and track performance over time. The measure we have described meets the National Quality Forum's measure evaluation criteria in that it addresses an important clinical topic for which there appears to be significant opportunities for improvement, the measure is precisely defined and has been subjected to validity and reliability testing, it is risk‐adjusted based on patient clinical factors present at the start of care, is feasible to produce, and is understandable by a broad range of potential users.21 Because hospitalists are the physicians primarily responsible for the care of patients with pneumonia at US hospitals, and because they frequently serve as the physician champions for quality improvement activities related to pneumonia, it is especially important that they maintain a thorough understanding of the measures and methodologies underlying current efforts to measure hospital performance.
Several features of our approach warrant additional comment. First, we deliberately chose to measure all readmission events rather than attempt to discriminate between potentially preventable and nonpreventable readmissions. From the patient perspective, readmission for any reason is a concern, and limiting the measure to pneumonia‐related readmissions could make it susceptible to gaming by hospitals. Moreover, determining whether a readmission is related to a potential quality problem is not straightforward. For example, a patient with pneumonia whose discharge medications were prescribed incorrectly may be readmitted with a hip fracture following an episode of syncope. It would be inappropriate to treat this readmission as unrelated to the care the patient received for pneumonia. Additionally, while our approach does not presume that every readmission is preventable, the goal is to reduce the risk of readmissions generally (not just in narrowly defined subpopulations), and successful interventions to reduce rehospitalization have typically demonstrated reductions in all‐cause readmission.9, 22 Second, deaths that occurred within 30 days of discharge, yet that were not accompanied by a hospital readmission, were not counted as a readmission outcome. While it may seem inappropriate to treat a postdischarge death as a nonevent (rather than censoring or excluding such cases), alternative analytic approaches, such as using a hierarchical survival model, are not currently computationally feasible with large national data sets. Fortunately, only a relatively small proportion of discharges fell into this category (5.2% of index cases in the 2006 development sample died within 30 days of discharge without being readmitted). An alternative approach to handling the competing outcome of death would have been to use a composite outcome of readmission or death. However, we believe that it is important to report the outcomes separately because factors that predict readmission and mortality may differ, and when making comparisons across hospitals it would not be possible to determine whether differences in rate were due to readmission or mortality. Third, while the patient‐level readmission model showed only modest discrimination, we intentionally excluded covariates such as race and socioeconomic status, as well as in‐hospital events and potential complications of care, and whether patients were discharged home or to a skilled nursing facility. While these variables could have improved predictive ability, they may be directly or indirectly related to quality or supply factors that should not be included in a model that seeks to control for patient clinical characteristics. For example, if hospitals with a large share of poor patients have higher readmission rates, then including income in the model will obscure differences that are important to identify. While we believe that the decision to exclude such factors in the model is in the best interest of patients, and supports efforts to reduce health inequality in society more generally, we also recognize that hospitals that care for a disproportionate share of poor patients are likely to require additional resources to overcome these social factors. Fourth, we limited the analysis to patients with a principal diagnosis of pneumonia, and chose not to also include those with a principal diagnosis of sepsis or respiratory failure coupled with a secondary diagnosis of pneumonia. While the broader definition is used by CMS in the National Pneumonia Project, that initiative relied on chart abstraction to differentiate pneumonia present at the time of admission from cases developing as a complication of hospitalization. Additionally, we did not attempt to differentiate between community‐acquired and healthcare‐associated pneumonia, however our approach is consistent with the National Pneumonia Project and Pneumonia Patient Outcomes Research Team.18 Fifth, while our model estimates readmission rates at the hospital level, we recognize that readmissions are influenced by a complex and extensive range of factors. In this context, greater cooperation between hospitals and other care providers will almost certainly be required in order to achieve dramatic improvement in readmission rates, which in turn will depend upon changes to the way serious illness is paid for. Some options that have recently been described include imposing financial penalties for early readmission, extending the boundaries of case‐based payment beyond hospital discharge, and bundling payments between hospitals and physicians.2325
Our measure has several limitations. First, our models were developed and validated using Medicare data, and the results may not apply to pneumonia patients less than 65 years of age. However, most patients hospitalized with pneumonia in the US are 65 or older. In addition, we were unable to test the model with a Medicare managed care population, because data are not currently available on such patients. Finally, the medical record‐based validation was conducted by state‐level analysis because the sample size was insufficient to carry this out at the hospital level.
In conclusion, more than 17% of Medicare beneficiaries are readmitted within 30 days following discharge after a hospitalization for pneumonia, and rates vary substantially across institutions. The development of a valid measure of hospital performance and public reporting are important first steps towards focusing attention on this problem. Actual improvement will now depend on whether hospitals and partner organizations are successful at identifying and implementing effective methods to prevent readmission.
- Rehospitalizations among patients in the Medicare Fee‐for‐Service Program.N Engl J Med.2009;360(14):1418–1428. , , .
- Medicare Payment Advisory Commission.Report to the Congress: Promoting Greater Efficiency in Medicare.2007.
- 2009. Available at: http://www.hcup‐us.ahrq.gov/reports.jsp. Accessed November 7, 2009. , , , , . HCUP Facts and Figures: Statistics on Hospital‐based Care in the United States, 2007.
- Centers for Medicare 353(3):255–264.
- Trends in postdischarge mortality and readmissions: has length of stay declined too far?Arch Intern Med.2004;164(5):538–544. , , , .
- Short‐term outcomes and their predictors for patients hospitalized with community‐acquired pneumonia.Heart Lung.2004;33(5):301–307. , , , .
- Improved clinical outcomes with utilization of a community‐acquired pneumonia guideline.Chest.2006;130(3):794–799. , , , et al.
- Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia.Arch Intern Med.1999;159(21):2562–2572. , , , , .
- Hospital readmissions as a measure of quality of health care: advantages and limitations.Arch Intern Med.2000;160(8):1074–1081. , .
- The care transitions intervention: results of a randomized controlled trial.Arch Intern Med.2006;166(17):1822–1828. , , , .
- Corrigan JM, Eden J, Smith BM, eds.Leadership by Example: Coordinating Government Roles in Improving Health Care Quality. Committee on Enhancing Federal Healthcare Quality Programs.Washington, DC:National Academies Press,2003.
- Medicare.gov—Hospital Compare. Available at: http://www.hospitalcompare.hhs.gov/Hospital/Search/Welcome.asp?version=default1(1):29–37.
- Measuring performance for treating heart attacks and heart failure: the case for outcomes measurement.Health Aff.2007;26(1):75–85. , , , , .
- NQF‐Endorsed® Standards. Available at: http://www.qualityforum.org/Measures_List.aspx. Accessed November 6,2009.
- Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community‐acquired pneumonia.Arch Intern Med.2004;164(6):637–644. , , , , .
- 2000. Available at: http://www.cms.hhs.gov/Reports/Reports/ItemDetail.asp?ItemID=CMS023176. Accessed November 7, 2009. , , . Diagnostic Cost Group Hierarchical Condition Category Models for Medicare Risk Adjustment. Report prepared for the Health Care Financing Administration. Health Economics Research, Inc;
- Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis.1st ed.New York:Springer;2006. .
- National Quality Forum—Measure Evaluation Criteria.2008. Available at: http://www.qualityforum.org/uploadedFiles/Quality_Forum/Measuring_Performance/Consensus_Development_Process%E2%80%99s_Principle/EvalCriteria2008–08‐28Final.pdf?n=4701.
- Comprehensive discharge planning and home follow‐up of hospitalized elders: a randomized clinical trial.JAMA.1999;281(7):613–620. , , , et al.
- Paying for care episodes and care coordination.N Engl J Med.2007;356(11):1166–1168. .
- Health care reform—toward more freedom, and responsibility, for physicians.N Engl J Med.2009;361(6):623–628. .
- Beyond pay for performance—emerging models of provider‐payment reform.N Engl J Med.2008;359(12):1197–1200. .
Hospital readmissions are emblematic of the numerous challenges facing the US health care system. Despite high levels of spending, nearly 20% of Medicare beneficiaries are readmitted within 30 days of hospital discharge, many readmissions are considered preventable, and rates vary widely by hospital and region.1 Further, while readmissions have been estimated to cost taxpayers as much as $17 billion annually, the current fee‐for‐service method of paying for the acute care needs of seniors rewards hospitals financially for readmission, not their prevention.2
Pneumonia is the second most common reason for hospitalization among Medicare beneficiaries, accounting for approximately 650,000 admissions annually,3 and has been a focus of national quality‐improvement efforts for more than a decade.4, 5 Despite improvements in key processes of care, rates of readmission within 30 days of discharge following a hospitalization for pneumonia have been reported to vary from 10% to 24%.68 Among several factors, readmissions are believed to be influenced by the quality of both inpatient and outpatient care, and by care‐coordination activities occurring in the transition from inpatient to outpatient status.912
Public reporting of hospital performance is considered a key strategy for improving quality, reducing costs, and increasing the value of hospital care, both in the US and worldwide.13 In 2009, the Centers for Medicare & Medicaid Services (CMS) expanded its reporting initiatives by adding risk‐adjusted hospital readmission rates for acute myocardial infarction, heart failure, and pneumonia to the Hospital Compare website.14, 15 Readmission rates are an attractive focus for public reporting for several reasons. First, in contrast to most process‐based measures of quality (eg, whether a patient with pneumonia received a particular antibiotic), a readmission is an adverse outcome that matters to patients and families.16 Second, unlike process measures whose assessment requires detailed review of medical records, readmissions can be easily determined from standard hospital claims. Finally, readmissions are costly, and their prevention could yield substantial savings to society.
A necessary prerequisite for public reporting of readmission is a validated, risk‐adjusted measure that can be used to track performance over time and can facilitate comparisons across institutions. Toward this end, we describe the development, validation, and results of a National Quality Forum‐approved and CMS‐adopted model to estimate hospital‐specific, risk‐standardized, 30‐day readmission rates for Medicare patients hospitalized with pneumonia.17
METHODS
Data Sources
We used 20052006 claims data from Medicare inpatient, outpatient, and carrier (physician) Standard Analytic Files to develop and validate the administrative model. The Medicare Enrollment Database was used to determine Medicare fee‐for‐service enrollment and mortality statuses. A medical record model, used for additional validation of the administrative model, was developed using information abstracted from the charts of 75,616 pneumonia cases from 19982001 as part of the National Pneumonia Project, a CMS quality improvement initiative.18
Study Cohort
We identified hospitalizations of patients 65 years of age and older with a principal diagnosis of pneumonia (International Classification of Diseases, 9th Revision, Clinical Modification codes 480.XX, 481, 482.XX, 483.X, 485, 486, 487.0) as potential index pneumonia admissions. Because our focus was readmission for patients discharged from acute care settings, we excluded admissions in which patients died or were transferred to another acute care facility. Additionally, we restricted analysis to patients who had been enrolled in fee‐for‐service Medicare Parts A and B, for at least 12 months prior to their pneumonia hospitalization, so that we could use diagnostic codes from all inpatient and outpatient encounters during that period to enhance identification of comorbidities.
Outcome
The outcome was 30‐day readmission, defined as occurrence of at least one hospitalization for any cause within 30 days of discharge after an index admission. Readmissions were identified from hospital claims data, and were attributed to the hospital that had discharged the patient. A 30‐day time frame was selected because it is a clinically meaningful period during which hospitals can be expected to collaborate with other organizations and providers to implement measures to reduce the risk of rehospitalization.
Candidate and Final Model Variables
Candidate variables for the administrative claims model were selected by a clinician team from 189 diagnostic groups included in the Hierarchical Condition Category (HCC) clinical classification system.19 The HCC clinical classification system was developed for CMS in preparation for all‐encounter risk adjustment for Medicare Advantage (managed care). Under the HCC algorithm, the 15,000+ ICD‐9‐CM diagnosis codes are assigned to one of 189 clinically‐coherent condition categories (CCs). We used the April 2008 version of the ICD‐9‐CM to CC assignment map, which is maintained by CMS and posted at
The final risk‐adjustment model included 39 variables selected by the team of clinicians and analysts, primarily based on their clinical relevance but also with knowledge of the strength of their statistical association with readmission outcome (Table 1). For each patient, the presence or absence of these conditions was assessed from multiple sources, including secondary diagnoses during the index admission, principal and secondary diagnoses from hospital admissions in the 12 months prior to the index admission, and diagnoses from hospital outpatient and physician encounters 12 months before the index admission. A small number of CCs were considered to represent potential complications of care (eg, bleeding). Because we did not want to adjust for complications of care occurring during the index admission, a patient was not considered to have one of these conditions unless it was also present in at least one encounter prior to the index admission.
Variable | Frequencies | Estimate | Standard Error | Odds Ratio | 95% CI | |
---|---|---|---|---|---|---|
| ||||||
Intercept | 2.395 | 0.021 | ||||
Age 65 (years above 65, continuous) | 0.0001 | 0.001 | 1.000 | 0.998 | 1.001 | |
Male | 45 | 0.071 | 0.012 | 1.073 | 1.048 | 1.099 |
History of CABG | 5.2 | 0.179 | 0.027 | 0.836 | 0.793 | 0.881 |
Metastatic cancer and acute leukemia (CC 7) | 4.3 | 0.177 | 0.029 | 1.194 | 1.128 | 1.263 |
Lung, upper digestive tract, and other severe cancers (CC 8) | 6.0 | 0.256 | 0.024 | 1.292 | 1.232 | 1.354 |
Diabetes and DM complications (CC 15‐20, 119, 120) | 36 | 0.059 | 0.012 | 1.061 | 1.036 | 1.087 |
Disorders of fluid/electrolyte/acid‐base (CC 22, 23) | 34 | 0.149 | 0.013 | 1.160 | 1.131 | 1.191 |
Iron deficiency and other/unspecified anemias and blood disease (CC 47) | 46 | 0.118 | 0.012 | 1.126 | 1.099 | 1.153 |
Other psychiatric disorders (CC 60) | 12 | 0.108 | 0.017 | 1.114 | 1.077 | 1.151 |
Cardio‐respiratory failure and shock (CC 79) | 16 | 0.114 | 0.016 | 1.121 | 1.087 | 1.156 |
Congestive heart failure (CC 80) | 39 | 0.151 | 0.014 | 1.163 | 1.133 | 1.194 |
Chronic atherosclerosis (CC 83, 84) | 47 | 0.051 | 0.013 | 1.053 | 1.027 | 1.079 |
Valvular and rheumatic heart disease (CC 86) | 23 | 0.062 | 0.014 | 1.064 | 1.036 | 1.093 |
Arrhythmias (CC 92, 93) | 38 | 0.126 | 0.013 | 1.134 | 1.107 | 1.163 |
Vascular or circulatory disease (CC 104‐106) | 38 | 0.088 | 0.012 | 1.092 | 1.066 | 1.119 |
COPD (CC 108) | 58 | 0.186 | 0.013 | 1.205 | 1.175 | 1.235 |
Fibrosis of lung and other chronic lung disorders (CC 109) | 17 | 0.086 | 0.015 | 1.090 | 1.059 | 1.122 |
Renal failure (CC 131) | 17 | 0.147 | 0.016 | 1.158 | 1.122 | 1.196 |
Protein‐calorie malnutrition (CC 21) | 7.9 | 0.121 | 0.020 | 1.129 | 1.086 | 1.173 |
History of infection (CC 1, 3‐6) | 35 | 0.068 | 0.012 | 1.071 | 1.045 | 1.097 |
Severe hematological disorders (CC 44) | 3.6 | 0.117 | 0.028 | 1.125 | 1.064 | 1.188 |
Decubitus ulcer or chronic skin ulcer (CC 148, 149) | 10 | 0.101 | 0.018 | 1.106 | 1.067 | 1.146 |
History of pneumonia (CC 111‐113) | 44 | 0.065 | 0.013 | 1.067 | 1.041 | 1.094 |
Vertebral fractures (CC 157) | 5.1 | 0.113 | 0.024 | 1.120 | 1.068 | 1.174 |
Other injuries (CC 162) | 32 | 0.061 | 0.012 | 1.063 | 1.038 | 1.089 |
Urinary tract infection (CC 135) | 26 | 0.064 | 0.014 | 1.066 | 1.038 | 1.095 |
Lymphatic, head and neck, brain, and other major cancers; breast, prostate, colorectal, and other cancers and tumors (CC 9‐10) | 16 | 0.050 | 0.016 | 1.051 | 1.018 | 1.084 |
End‐stage renal disease or dialysis (CC 129, 130) | 1.9 | 0.131 | 0.037 | 1.140 | 1.060 | 1.226 |
Drug/alcohol abuse/dependence/psychosis (CC 51‐53) | 12 | 0.081 | 0.017 | 1.084 | 1.048 | 1.121 |
Septicemia/shock (CC 2) | 6.3 | 0.094 | 0.022 | 1.098 | 1.052 | 1.146 |
Other gastrointestinal disorders (CC 36) | 56 | 0.073 | 0.012 | 1.076 | 1.051 | 1.102 |
Acute coronary syndrome (CC 81, 82) | 8.3 | 0.126 | 0.019 | 1.134 | 1.092 | 1.178 |
Pleural effusion/pneumothorax (CC 114) | 12 | 0.083 | 0.017 | 1.086 | 1.051 | 1.123 |
Other urinary tract disorders (CC 136) | 24 | 0.059 | 0.014 | 1.061 | 1.033 | 1.090 |
Stroke (CC 95, 96) | 10 | 0.047 | 0.019 | 1.049 | 1.011 | 1.088 |
Dementia and senility (CC 49, 50) | 27 | 0.031 | 0.014 | 1.031 | 1.004 | 1.059 |
Hemiplegia, paraplegia, paralysis, functional disability (CC 67‐69, 100‐102, 177, 178) | 7.4 | 0.068 | 0.021 | 1.070 | 1.026 | 1.116 |
Other lung disorders (CC 115) | 45 | 0.005 | 0.012 | 1.005 | 0.982 | 1.030 |
Major psychiatric disorders (CC 54‐56) | 11 | 0.038 | 0.018 | 1.038 | 1.003 | 1.075 |
Asthma (CC 110) | 12 | 0.006 | 0.018 | 1.006 | 0.972 | 1.041 |
Model Derivation
For the development of the administrative claims model, we randomly sampled half of 2006 hospitalizations that met inclusion criteria. To assess model performance at the patient level, we calculated the area under the receiver operating curve (AUC), and calculated observed readmission rates in the lowest and highest deciles on the basis of predicted readmission probabilities. We also compared performance with a null model, a model that adjusted for age and sex, and a model that included all candidate variables.20
Risk‐Standardized Readmission Rates
Using hierarchical logistic regression, we modeled the log‐odds of readmission within 30 days of discharge from an index pneumonia admission as a function of patient demographic and clinical characteristics, and a random hospital‐specific intercept. This strategy accounts for within‐hospital correlation, or clustering, of observed outcomes, and models the assumption that underlying differences in quality among hospitals being evaluated lead to systematic differences in outcomes. We then calculated hospital‐specific readmission rates as the ratio of predicted‐to‐expected readmissions (similar to observed/expected ratio), multiplied by the national unadjusted ratea form of indirect standardization. Predicted number of readmissions in each hospital is estimated given the same patient mix and its estimated hospital‐specific intercept. Expected number of readmissions in each hospital is estimated using its patient mix and the average hospital‐specific intercept. To assess hospital performance in any given year, we re‐estimate model coefficients using that year's data.
Model Validation: Administrative Claims
We compared the model performance in the development sample with its performance in the sample from the 2006 data that was not selected for the development set, and separately among pneumonia admissions in 2005. The model was recalibrated in each validation set.
Model Validation: Medical Record Abstraction
We developed a separate medical record‐based model of readmission risk using information from charts that had previously been abstracted as part of CMS's National Pneumonia Project. To select variables for this model, the clinician team: 1) reviewed the list of variables that were included in a medical record model that was previously developed for validating the National Quality Forum‐approved pneumonia mortality measure; 2) reviewed a list of other potential candidate variables available in the National Pneumonia Project dataset; and 3) reviewed variables that emerged as potentially important predictors of readmission, based on a systematic review of the literature that was conducted as part of measure development. This selection process resulted in a final medical record model that included 35 variables.
We linked patients in the National Pneumonia Project cohort to their Medicare claims data, including claims from one year before the index hospitalization, so that we could calculate risk‐standardized readmission rates in this cohort separately using medical record and claims‐based models. This analysis was conducted at the state level, for the 50 states plus the District of Columbia and Puerto Rico, because medical record data were unavailable in sufficient numbers to permit hospital‐level comparisons. To examine the relationship between risk‐standardized rates obtained from medical record and administrative data models, we estimated a linear regression model describing the association between the two rates, weighting each state by number of index hospitalizations, and calculated the correlation coefficient and the intercept and slope of this equation. A slope close to 1 and an intercept close to 0 would provide evidence that risk‐standardized state readmission rates from the medical record and claims models were similar. We also calculated the difference between state risk‐standardized readmission rates from the two models.
Analyses were conducted with the use of SAS version 9.1.3 (SAS Institute Inc, Cary, NC). Models were fitted separately for the National Pneumonia Project and 2006 cohort. We estimated the hierarchical models using the GLIMMIX procedure in SAS. The Human Investigation Committee at the Yale School of Medicine approved an exemption for the authors to use CMS claims and enrollment data for research analyses and publication.
RESULTS
Model Derivation and Performance
After exclusions were applied, the 2006 sample included 453,251 pneumonia hospitalizations (Figure 1). The development sample consisted of 226,545 hospitalizations at 4675 hospitals, with an overall unadjusted 30‐day readmission rate of 17.4%. In 11,694 index cases (5.2%), the patient died within 30 days without being readmitted. Median readmission rate was 16.3%, 25th and 75th percentile rates were 11.1% and 21.3%, and at the 10th and 90th percentile, hospital readmission rates ranged from 4.6% to 26.7% (Figure 2).
The claims model included 39 variables (age, sex, and 37 clinical variables) (Table 1). The mean age of the cohort was 80.0 years, with 55.5% women and 11.1% nonwhite patients. Mean observed readmission rate in the development sample ranged from 9% in the lowest decile of predicted pneumonia readmission rates to 32% in the highest predicted decile, a range of 23%. The AUC was 0.63. For comparison, a model with only age and sex had an AUC of 0.51, and a model with all candidate variables had an AUC equal to 0.63 (Table 2).
Calibration (0, 1)* | Discrimination | Residuals Lack of Fit (Pearson Residual Fall %) | Model 2 (No. of Covariates) | ||||||
---|---|---|---|---|---|---|---|---|---|
Predictive Ability (Lowest Decile, Highest Decile) | AUC | (<2) | (2, 0) | (0, 2) | (2+) | ||||
| |||||||||
Development sample | |||||||||
2006 | (1st half) N = 226,545 | (0, 1) | (0.09, 0.32) | 0.63 | 0 | 82.62 | 7.39 | 9.99 | 6,843 (40) |
Validation sample | |||||||||
2006 | (2nd half) N = 226,706 | (0.002, 0.997) | (0.09, 0.31) | 0.63 | 0 | 82.55 | 7.45 | 9.99 | 6,870 (40) |
2005 | N = 536,015 | (0.035, 1.008) | (0.08, 0.31) | 0.63 | 0 | 82.67 | 7.31 | 10.03 | 16,241 (40) |
Hospital Risk‐Standardized Readmission Rates
Risk‐standardized readmission rates varied across hospitals (Figure 3). Median risk‐standardized readmission rate was 17.3%, and the 25th and 75th percentiles were 16.9% and 17.9%, respectively. The 5th percentile was 16.0% and the 95th percentile was 19.1%. Odds of readmission for a hospital one standard deviation above average was 1.4 times that of a hospital one standard deviation below average.
Administrative Model Validation
In the remaining 50% of pneumonia index hospitalizations from 2006, and the entire 2005 cohort, regression coefficients and standard errors of model variables were similar to those in the development data set. Model performance using 2005 data was consistent with model performance using the 2006 development and validation half‐samples (Table 2).
Medical Record Validation
After exclusions, the medical record sample taken from the National Pneumonia Project included 47,429 cases, with an unadjusted 30‐day readmission rate of 17.0%. The final medical record risk‐adjustment model included a total of 35 variables, whose prevalence and association with readmission risk varied modestly (Table 3). Performance of the medical record and administrative models was similar (areas under the ROC curve 0.59 and 0.63, respectively) (Table 4). Additionally, in the administrative model, predicted readmission rates ranged from 8% in the lowest predicted decile to 30% in the highest predicted decile, while in the medical record model, the corresponding rates varied from 10% to 26%.
Variable | Percent | Estimate | Standard Error | Odds Ratio | 95% CI | |
---|---|---|---|---|---|---|
| ||||||
Age 65, mean (SD) | 15.24 (7.87) | 0.003 | 0.002 | 0.997 | 0.993 | 1.000 |
Male | 46.18 | 0.122 | 0.025 | 1.130 | 1.075 | 1.188 |
Nursing home resident | 17.71 | 0.035 | 0.037 | 1.036 | 0.963 | 1.114 |
Neoplastic disease | 6.80 | 0.130 | 0.049 | 1.139 | 1.034 | 1.254 |
Liver disease | 1.04 | 0.089 | 0.123 | 0.915 | 0.719 | 1.164 |
History of heart failure | 28.98 | 0.234 | 0.029 | 1.264 | 1.194 | 1.339 |
History of renal disease | 8.51 | 0.188 | 0.047 | 1.206 | 1.100 | 1.323 |
Altered mental status | 17.95 | 0.009 | 0.034 | 1.009 | 0.944 | 1.080 |
Pleural effusion | 21.20 | 0.165 | 0.030 | 1.179 | 1.111 | 1.251 |
BUN 30 mg/dl | 23.28 | 0.160 | 0.033 | 1.174 | 1.100 | 1.252 |
BUN missing | 14.56 | 0.101 | 0.185 | 0.904 | 0.630 | 1.298 |
Systolic BP <90 mmHg | 2.95 | 0.068 | 0.070 | 1.070 | 0.932 | 1.228 |
Systolic BP missing | 11.21 | 0.149 | 0.425 | 1.160 | 0.504 | 2.669 |
Pulse 125/min | 7.73 | 0.036 | 0.047 | 1.036 | 0.945 | 1.137 |
Pulse missing | 11.22 | 0.210 | 0.405 | 1.234 | 0.558 | 2.729 |
Respiratory rate 30/min | 16.38 | 0.079 | 0.034 | 1.082 | 1.012 | 1.157 |
Respiratory rate missing | 11.39 | 0.204 | 0.240 | 1.226 | 0.765 | 1.964 |
Sodium <130 mmol/L | 4.82 | 0.136 | 0.057 | 1.145 | 1.025 | 1.280 |
Sodium missing | 14.39 | 0.049 | 0.143 | 1.050 | 0.793 | 1.391 |
Glucose 250 mg/dl | 5.19 | 0.005 | 0.057 | 0.995 | 0.889 | 1.114 |
Glucose missing | 15.44 | 0.156 | 0.105 | 0.855 | 0.696 | 1.051 |
Hematocrit <30% | 7.77 | 0.270 | 0.044 | 1.310 | 1.202 | 1.428 |
Hematocrit missing | 13.62 | 0.071 | 0.135 | 0.932 | 0.715 | 1.215 |
Creatinine 2.5 mg/dL | 4.68 | 0.109 | 0.062 | 1.115 | 0.989 | 1.258 |
Creatinine missing | 14.63 | 0.200 | 0.167 | 1.221 | 0.880 | 1.695 |
WBC 6‐12 b/L | 38.04 | 0.021 | 0.049 | 0.979 | 0.889 | 1.079 |
WBC >12 b/L | 41.45 | 0.068 | 0.049 | 0.934 | 0.848 | 1.029 |
WBC missing | 12.85 | 0.167 | 0.162 | 1.181 | 0.860 | 1.623 |
Immunosuppressive therapy | 15.01 | 0.347 | 0.035 | 1.415 | 1.321 | 1.516 |
Chronic lung disease | 42.16 | 0.137 | 0.028 | 1.147 | 1.086 | 1.211 |
Coronary artery disease | 39.57 | 0.150 | 0.028 | 1.162 | 1.100 | 1.227 |
Diabetes mellitus | 20.90 | 0.137 | 0.033 | 1.147 | 1.076 | 1.223 |
Alcohol/drug abuse | 3.40 | 0.099 | 0.071 | 0.906 | 0.788 | 1.041 |
Dementia/Alzheimer's disease | 16.38 | 0.125 | 0.038 | 1.133 | 1.052 | 1.222 |
Splenectomy | 0.44 | 0.016 | 0.186 | 1.016 | 0.706 | 1.463 |
Model | Calibration (0, 1)* | Discrimination | Residuals Lack of Fit (Pearson Residual Fall %) | Model 2 (No. of Covariates) | ||||
---|---|---|---|---|---|---|---|---|
Predictive Ability (Lowest Decile, Highest Decile) | AUC | (<2) | (2, 0) | (0, 2) | (2+) | |||
| ||||||||
Medical Record Model Development Sample (NP) | ||||||||
N = 47,429 No. of 30‐day readmissions = 8,042 | (1, 0) | (0.10, 0.26) | 0.59 | 0 | 83.04 | 5.28 | 11.68 | 710 (35) |
Linked Administrative Model Validation Sample | ||||||||
N = 47,429 No. of 30‐day readmissions = 8,042 | (1, 0) | (0.08, 0.30) | 0.63 | 0 | 83.04 | 6.94 | 10.01 | 1,414 (40) |
The correlation coefficient of the estimated state‐specific standardized readmission rates from the administrative and medical record models was 0.96, and the proportion of the variance explained by the model was 0.92 (Figure 4).
DISCUSSION
We have described the development, validation, and results of a hospital, 30‐day, risk‐standardized readmission model for pneumonia that was created to support current federal transparency initiatives. The model uses administrative claims data from Medicare fee‐for‐service patients and produces results that are comparable to a model based on information obtained through manual abstraction of medical records. We observed an overall 30‐day readmission rate of 17%, and our analyses revealed substantial variation across US hospitals, suggesting that improvement by lower performing institutions is an achievable goal.
Because more than one in six pneumonia patients are rehospitalized shortly after discharge, and because pneumonia hospitalizations represent an enormous expense to the Medicare program, prevention of readmissions is now widely recognized to offer a substantial opportunity to improve patient outcomes while simultaneously lowering health care costs. Accordingly, promotion of strategies to reduce readmission rates has become a key priority for payers and quality‐improvement organizations. These range from policy‐level attempts to stimulate change, such as publicly reporting hospital readmission rates on government websites, to establishing accreditation standardssuch as the Joint Commission's requirement to accurately reconcile medications, to the creation of quality improvement collaboratives focused on sharing best practices across institutions. Regardless of the approach taken, a valid, risk‐adjusted measure of performance is required to evaluate and track performance over time. The measure we have described meets the National Quality Forum's measure evaluation criteria in that it addresses an important clinical topic for which there appears to be significant opportunities for improvement, the measure is precisely defined and has been subjected to validity and reliability testing, it is risk‐adjusted based on patient clinical factors present at the start of care, is feasible to produce, and is understandable by a broad range of potential users.21 Because hospitalists are the physicians primarily responsible for the care of patients with pneumonia at US hospitals, and because they frequently serve as the physician champions for quality improvement activities related to pneumonia, it is especially important that they maintain a thorough understanding of the measures and methodologies underlying current efforts to measure hospital performance.
Several features of our approach warrant additional comment. First, we deliberately chose to measure all readmission events rather than attempt to discriminate between potentially preventable and nonpreventable readmissions. From the patient perspective, readmission for any reason is a concern, and limiting the measure to pneumonia‐related readmissions could make it susceptible to gaming by hospitals. Moreover, determining whether a readmission is related to a potential quality problem is not straightforward. For example, a patient with pneumonia whose discharge medications were prescribed incorrectly may be readmitted with a hip fracture following an episode of syncope. It would be inappropriate to treat this readmission as unrelated to the care the patient received for pneumonia. Additionally, while our approach does not presume that every readmission is preventable, the goal is to reduce the risk of readmissions generally (not just in narrowly defined subpopulations), and successful interventions to reduce rehospitalization have typically demonstrated reductions in all‐cause readmission.9, 22 Second, deaths that occurred within 30 days of discharge, yet that were not accompanied by a hospital readmission, were not counted as a readmission outcome. While it may seem inappropriate to treat a postdischarge death as a nonevent (rather than censoring or excluding such cases), alternative analytic approaches, such as using a hierarchical survival model, are not currently computationally feasible with large national data sets. Fortunately, only a relatively small proportion of discharges fell into this category (5.2% of index cases in the 2006 development sample died within 30 days of discharge without being readmitted). An alternative approach to handling the competing outcome of death would have been to use a composite outcome of readmission or death. However, we believe that it is important to report the outcomes separately because factors that predict readmission and mortality may differ, and when making comparisons across hospitals it would not be possible to determine whether differences in rate were due to readmission or mortality. Third, while the patient‐level readmission model showed only modest discrimination, we intentionally excluded covariates such as race and socioeconomic status, as well as in‐hospital events and potential complications of care, and whether patients were discharged home or to a skilled nursing facility. While these variables could have improved predictive ability, they may be directly or indirectly related to quality or supply factors that should not be included in a model that seeks to control for patient clinical characteristics. For example, if hospitals with a large share of poor patients have higher readmission rates, then including income in the model will obscure differences that are important to identify. While we believe that the decision to exclude such factors in the model is in the best interest of patients, and supports efforts to reduce health inequality in society more generally, we also recognize that hospitals that care for a disproportionate share of poor patients are likely to require additional resources to overcome these social factors. Fourth, we limited the analysis to patients with a principal diagnosis of pneumonia, and chose not to also include those with a principal diagnosis of sepsis or respiratory failure coupled with a secondary diagnosis of pneumonia. While the broader definition is used by CMS in the National Pneumonia Project, that initiative relied on chart abstraction to differentiate pneumonia present at the time of admission from cases developing as a complication of hospitalization. Additionally, we did not attempt to differentiate between community‐acquired and healthcare‐associated pneumonia, however our approach is consistent with the National Pneumonia Project and Pneumonia Patient Outcomes Research Team.18 Fifth, while our model estimates readmission rates at the hospital level, we recognize that readmissions are influenced by a complex and extensive range of factors. In this context, greater cooperation between hospitals and other care providers will almost certainly be required in order to achieve dramatic improvement in readmission rates, which in turn will depend upon changes to the way serious illness is paid for. Some options that have recently been described include imposing financial penalties for early readmission, extending the boundaries of case‐based payment beyond hospital discharge, and bundling payments between hospitals and physicians.2325
Our measure has several limitations. First, our models were developed and validated using Medicare data, and the results may not apply to pneumonia patients less than 65 years of age. However, most patients hospitalized with pneumonia in the US are 65 or older. In addition, we were unable to test the model with a Medicare managed care population, because data are not currently available on such patients. Finally, the medical record‐based validation was conducted by state‐level analysis because the sample size was insufficient to carry this out at the hospital level.
In conclusion, more than 17% of Medicare beneficiaries are readmitted within 30 days following discharge after a hospitalization for pneumonia, and rates vary substantially across institutions. The development of a valid measure of hospital performance and public reporting are important first steps towards focusing attention on this problem. Actual improvement will now depend on whether hospitals and partner organizations are successful at identifying and implementing effective methods to prevent readmission.
Hospital readmissions are emblematic of the numerous challenges facing the US health care system. Despite high levels of spending, nearly 20% of Medicare beneficiaries are readmitted within 30 days of hospital discharge, many readmissions are considered preventable, and rates vary widely by hospital and region.1 Further, while readmissions have been estimated to cost taxpayers as much as $17 billion annually, the current fee‐for‐service method of paying for the acute care needs of seniors rewards hospitals financially for readmission, not their prevention.2
Pneumonia is the second most common reason for hospitalization among Medicare beneficiaries, accounting for approximately 650,000 admissions annually,3 and has been a focus of national quality‐improvement efforts for more than a decade.4, 5 Despite improvements in key processes of care, rates of readmission within 30 days of discharge following a hospitalization for pneumonia have been reported to vary from 10% to 24%.68 Among several factors, readmissions are believed to be influenced by the quality of both inpatient and outpatient care, and by care‐coordination activities occurring in the transition from inpatient to outpatient status.912
Public reporting of hospital performance is considered a key strategy for improving quality, reducing costs, and increasing the value of hospital care, both in the US and worldwide.13 In 2009, the Centers for Medicare & Medicaid Services (CMS) expanded its reporting initiatives by adding risk‐adjusted hospital readmission rates for acute myocardial infarction, heart failure, and pneumonia to the Hospital Compare website.14, 15 Readmission rates are an attractive focus for public reporting for several reasons. First, in contrast to most process‐based measures of quality (eg, whether a patient with pneumonia received a particular antibiotic), a readmission is an adverse outcome that matters to patients and families.16 Second, unlike process measures whose assessment requires detailed review of medical records, readmissions can be easily determined from standard hospital claims. Finally, readmissions are costly, and their prevention could yield substantial savings to society.
A necessary prerequisite for public reporting of readmission is a validated, risk‐adjusted measure that can be used to track performance over time and can facilitate comparisons across institutions. Toward this end, we describe the development, validation, and results of a National Quality Forum‐approved and CMS‐adopted model to estimate hospital‐specific, risk‐standardized, 30‐day readmission rates for Medicare patients hospitalized with pneumonia.17
METHODS
Data Sources
We used 20052006 claims data from Medicare inpatient, outpatient, and carrier (physician) Standard Analytic Files to develop and validate the administrative model. The Medicare Enrollment Database was used to determine Medicare fee‐for‐service enrollment and mortality statuses. A medical record model, used for additional validation of the administrative model, was developed using information abstracted from the charts of 75,616 pneumonia cases from 19982001 as part of the National Pneumonia Project, a CMS quality improvement initiative.18
Study Cohort
We identified hospitalizations of patients 65 years of age and older with a principal diagnosis of pneumonia (International Classification of Diseases, 9th Revision, Clinical Modification codes 480.XX, 481, 482.XX, 483.X, 485, 486, 487.0) as potential index pneumonia admissions. Because our focus was readmission for patients discharged from acute care settings, we excluded admissions in which patients died or were transferred to another acute care facility. Additionally, we restricted analysis to patients who had been enrolled in fee‐for‐service Medicare Parts A and B, for at least 12 months prior to their pneumonia hospitalization, so that we could use diagnostic codes from all inpatient and outpatient encounters during that period to enhance identification of comorbidities.
Outcome
The outcome was 30‐day readmission, defined as occurrence of at least one hospitalization for any cause within 30 days of discharge after an index admission. Readmissions were identified from hospital claims data, and were attributed to the hospital that had discharged the patient. A 30‐day time frame was selected because it is a clinically meaningful period during which hospitals can be expected to collaborate with other organizations and providers to implement measures to reduce the risk of rehospitalization.
Candidate and Final Model Variables
Candidate variables for the administrative claims model were selected by a clinician team from 189 diagnostic groups included in the Hierarchical Condition Category (HCC) clinical classification system.19 The HCC clinical classification system was developed for CMS in preparation for all‐encounter risk adjustment for Medicare Advantage (managed care). Under the HCC algorithm, the 15,000+ ICD‐9‐CM diagnosis codes are assigned to one of 189 clinically‐coherent condition categories (CCs). We used the April 2008 version of the ICD‐9‐CM to CC assignment map, which is maintained by CMS and posted at
The final risk‐adjustment model included 39 variables selected by the team of clinicians and analysts, primarily based on their clinical relevance but also with knowledge of the strength of their statistical association with readmission outcome (Table 1). For each patient, the presence or absence of these conditions was assessed from multiple sources, including secondary diagnoses during the index admission, principal and secondary diagnoses from hospital admissions in the 12 months prior to the index admission, and diagnoses from hospital outpatient and physician encounters 12 months before the index admission. A small number of CCs were considered to represent potential complications of care (eg, bleeding). Because we did not want to adjust for complications of care occurring during the index admission, a patient was not considered to have one of these conditions unless it was also present in at least one encounter prior to the index admission.
Variable | Frequencies | Estimate | Standard Error | Odds Ratio | 95% CI | |
---|---|---|---|---|---|---|
| ||||||
Intercept | 2.395 | 0.021 | ||||
Age 65 (years above 65, continuous) | 0.0001 | 0.001 | 1.000 | 0.998 | 1.001 | |
Male | 45 | 0.071 | 0.012 | 1.073 | 1.048 | 1.099 |
History of CABG | 5.2 | 0.179 | 0.027 | 0.836 | 0.793 | 0.881 |
Metastatic cancer and acute leukemia (CC 7) | 4.3 | 0.177 | 0.029 | 1.194 | 1.128 | 1.263 |
Lung, upper digestive tract, and other severe cancers (CC 8) | 6.0 | 0.256 | 0.024 | 1.292 | 1.232 | 1.354 |
Diabetes and DM complications (CC 15‐20, 119, 120) | 36 | 0.059 | 0.012 | 1.061 | 1.036 | 1.087 |
Disorders of fluid/electrolyte/acid‐base (CC 22, 23) | 34 | 0.149 | 0.013 | 1.160 | 1.131 | 1.191 |
Iron deficiency and other/unspecified anemias and blood disease (CC 47) | 46 | 0.118 | 0.012 | 1.126 | 1.099 | 1.153 |
Other psychiatric disorders (CC 60) | 12 | 0.108 | 0.017 | 1.114 | 1.077 | 1.151 |
Cardio‐respiratory failure and shock (CC 79) | 16 | 0.114 | 0.016 | 1.121 | 1.087 | 1.156 |
Congestive heart failure (CC 80) | 39 | 0.151 | 0.014 | 1.163 | 1.133 | 1.194 |
Chronic atherosclerosis (CC 83, 84) | 47 | 0.051 | 0.013 | 1.053 | 1.027 | 1.079 |
Valvular and rheumatic heart disease (CC 86) | 23 | 0.062 | 0.014 | 1.064 | 1.036 | 1.093 |
Arrhythmias (CC 92, 93) | 38 | 0.126 | 0.013 | 1.134 | 1.107 | 1.163 |
Vascular or circulatory disease (CC 104‐106) | 38 | 0.088 | 0.012 | 1.092 | 1.066 | 1.119 |
COPD (CC 108) | 58 | 0.186 | 0.013 | 1.205 | 1.175 | 1.235 |
Fibrosis of lung and other chronic lung disorders (CC 109) | 17 | 0.086 | 0.015 | 1.090 | 1.059 | 1.122 |
Renal failure (CC 131) | 17 | 0.147 | 0.016 | 1.158 | 1.122 | 1.196 |
Protein‐calorie malnutrition (CC 21) | 7.9 | 0.121 | 0.020 | 1.129 | 1.086 | 1.173 |
History of infection (CC 1, 3‐6) | 35 | 0.068 | 0.012 | 1.071 | 1.045 | 1.097 |
Severe hematological disorders (CC 44) | 3.6 | 0.117 | 0.028 | 1.125 | 1.064 | 1.188 |
Decubitus ulcer or chronic skin ulcer (CC 148, 149) | 10 | 0.101 | 0.018 | 1.106 | 1.067 | 1.146 |
History of pneumonia (CC 111‐113) | 44 | 0.065 | 0.013 | 1.067 | 1.041 | 1.094 |
Vertebral fractures (CC 157) | 5.1 | 0.113 | 0.024 | 1.120 | 1.068 | 1.174 |
Other injuries (CC 162) | 32 | 0.061 | 0.012 | 1.063 | 1.038 | 1.089 |
Urinary tract infection (CC 135) | 26 | 0.064 | 0.014 | 1.066 | 1.038 | 1.095 |
Lymphatic, head and neck, brain, and other major cancers; breast, prostate, colorectal, and other cancers and tumors (CC 9‐10) | 16 | 0.050 | 0.016 | 1.051 | 1.018 | 1.084 |
End‐stage renal disease or dialysis (CC 129, 130) | 1.9 | 0.131 | 0.037 | 1.140 | 1.060 | 1.226 |
Drug/alcohol abuse/dependence/psychosis (CC 51‐53) | 12 | 0.081 | 0.017 | 1.084 | 1.048 | 1.121 |
Septicemia/shock (CC 2) | 6.3 | 0.094 | 0.022 | 1.098 | 1.052 | 1.146 |
Other gastrointestinal disorders (CC 36) | 56 | 0.073 | 0.012 | 1.076 | 1.051 | 1.102 |
Acute coronary syndrome (CC 81, 82) | 8.3 | 0.126 | 0.019 | 1.134 | 1.092 | 1.178 |
Pleural effusion/pneumothorax (CC 114) | 12 | 0.083 | 0.017 | 1.086 | 1.051 | 1.123 |
Other urinary tract disorders (CC 136) | 24 | 0.059 | 0.014 | 1.061 | 1.033 | 1.090 |
Stroke (CC 95, 96) | 10 | 0.047 | 0.019 | 1.049 | 1.011 | 1.088 |
Dementia and senility (CC 49, 50) | 27 | 0.031 | 0.014 | 1.031 | 1.004 | 1.059 |
Hemiplegia, paraplegia, paralysis, functional disability (CC 67‐69, 100‐102, 177, 178) | 7.4 | 0.068 | 0.021 | 1.070 | 1.026 | 1.116 |
Other lung disorders (CC 115) | 45 | 0.005 | 0.012 | 1.005 | 0.982 | 1.030 |
Major psychiatric disorders (CC 54‐56) | 11 | 0.038 | 0.018 | 1.038 | 1.003 | 1.075 |
Asthma (CC 110) | 12 | 0.006 | 0.018 | 1.006 | 0.972 | 1.041 |
Model Derivation
For the development of the administrative claims model, we randomly sampled half of 2006 hospitalizations that met inclusion criteria. To assess model performance at the patient level, we calculated the area under the receiver operating curve (AUC), and calculated observed readmission rates in the lowest and highest deciles on the basis of predicted readmission probabilities. We also compared performance with a null model, a model that adjusted for age and sex, and a model that included all candidate variables.20
Risk‐Standardized Readmission Rates
Using hierarchical logistic regression, we modeled the log‐odds of readmission within 30 days of discharge from an index pneumonia admission as a function of patient demographic and clinical characteristics, and a random hospital‐specific intercept. This strategy accounts for within‐hospital correlation, or clustering, of observed outcomes, and models the assumption that underlying differences in quality among hospitals being evaluated lead to systematic differences in outcomes. We then calculated hospital‐specific readmission rates as the ratio of predicted‐to‐expected readmissions (similar to observed/expected ratio), multiplied by the national unadjusted ratea form of indirect standardization. Predicted number of readmissions in each hospital is estimated given the same patient mix and its estimated hospital‐specific intercept. Expected number of readmissions in each hospital is estimated using its patient mix and the average hospital‐specific intercept. To assess hospital performance in any given year, we re‐estimate model coefficients using that year's data.
Model Validation: Administrative Claims
We compared the model performance in the development sample with its performance in the sample from the 2006 data that was not selected for the development set, and separately among pneumonia admissions in 2005. The model was recalibrated in each validation set.
Model Validation: Medical Record Abstraction
We developed a separate medical record‐based model of readmission risk using information from charts that had previously been abstracted as part of CMS's National Pneumonia Project. To select variables for this model, the clinician team: 1) reviewed the list of variables that were included in a medical record model that was previously developed for validating the National Quality Forum‐approved pneumonia mortality measure; 2) reviewed a list of other potential candidate variables available in the National Pneumonia Project dataset; and 3) reviewed variables that emerged as potentially important predictors of readmission, based on a systematic review of the literature that was conducted as part of measure development. This selection process resulted in a final medical record model that included 35 variables.
We linked patients in the National Pneumonia Project cohort to their Medicare claims data, including claims from one year before the index hospitalization, so that we could calculate risk‐standardized readmission rates in this cohort separately using medical record and claims‐based models. This analysis was conducted at the state level, for the 50 states plus the District of Columbia and Puerto Rico, because medical record data were unavailable in sufficient numbers to permit hospital‐level comparisons. To examine the relationship between risk‐standardized rates obtained from medical record and administrative data models, we estimated a linear regression model describing the association between the two rates, weighting each state by number of index hospitalizations, and calculated the correlation coefficient and the intercept and slope of this equation. A slope close to 1 and an intercept close to 0 would provide evidence that risk‐standardized state readmission rates from the medical record and claims models were similar. We also calculated the difference between state risk‐standardized readmission rates from the two models.
Analyses were conducted with the use of SAS version 9.1.3 (SAS Institute Inc, Cary, NC). Models were fitted separately for the National Pneumonia Project and 2006 cohort. We estimated the hierarchical models using the GLIMMIX procedure in SAS. The Human Investigation Committee at the Yale School of Medicine approved an exemption for the authors to use CMS claims and enrollment data for research analyses and publication.
RESULTS
Model Derivation and Performance
After exclusions were applied, the 2006 sample included 453,251 pneumonia hospitalizations (Figure 1). The development sample consisted of 226,545 hospitalizations at 4675 hospitals, with an overall unadjusted 30‐day readmission rate of 17.4%. In 11,694 index cases (5.2%), the patient died within 30 days without being readmitted. Median readmission rate was 16.3%, 25th and 75th percentile rates were 11.1% and 21.3%, and at the 10th and 90th percentile, hospital readmission rates ranged from 4.6% to 26.7% (Figure 2).
The claims model included 39 variables (age, sex, and 37 clinical variables) (Table 1). The mean age of the cohort was 80.0 years, with 55.5% women and 11.1% nonwhite patients. Mean observed readmission rate in the development sample ranged from 9% in the lowest decile of predicted pneumonia readmission rates to 32% in the highest predicted decile, a range of 23%. The AUC was 0.63. For comparison, a model with only age and sex had an AUC of 0.51, and a model with all candidate variables had an AUC equal to 0.63 (Table 2).
Calibration (0, 1)* | Discrimination | Residuals Lack of Fit (Pearson Residual Fall %) | Model 2 (No. of Covariates) | ||||||
---|---|---|---|---|---|---|---|---|---|
Predictive Ability (Lowest Decile, Highest Decile) | AUC | (<2) | (2, 0) | (0, 2) | (2+) | ||||
| |||||||||
Development sample | |||||||||
2006 | (1st half) N = 226,545 | (0, 1) | (0.09, 0.32) | 0.63 | 0 | 82.62 | 7.39 | 9.99 | 6,843 (40) |
Validation sample | |||||||||
2006 | (2nd half) N = 226,706 | (0.002, 0.997) | (0.09, 0.31) | 0.63 | 0 | 82.55 | 7.45 | 9.99 | 6,870 (40) |
2005 | N = 536,015 | (0.035, 1.008) | (0.08, 0.31) | 0.63 | 0 | 82.67 | 7.31 | 10.03 | 16,241 (40) |
Hospital Risk‐Standardized Readmission Rates
Risk‐standardized readmission rates varied across hospitals (Figure 3). Median risk‐standardized readmission rate was 17.3%, and the 25th and 75th percentiles were 16.9% and 17.9%, respectively. The 5th percentile was 16.0% and the 95th percentile was 19.1%. Odds of readmission for a hospital one standard deviation above average was 1.4 times that of a hospital one standard deviation below average.
Administrative Model Validation
In the remaining 50% of pneumonia index hospitalizations from 2006, and the entire 2005 cohort, regression coefficients and standard errors of model variables were similar to those in the development data set. Model performance using 2005 data was consistent with model performance using the 2006 development and validation half‐samples (Table 2).
Medical Record Validation
After exclusions, the medical record sample taken from the National Pneumonia Project included 47,429 cases, with an unadjusted 30‐day readmission rate of 17.0%. The final medical record risk‐adjustment model included a total of 35 variables, whose prevalence and association with readmission risk varied modestly (Table 3). Performance of the medical record and administrative models was similar (areas under the ROC curve 0.59 and 0.63, respectively) (Table 4). Additionally, in the administrative model, predicted readmission rates ranged from 8% in the lowest predicted decile to 30% in the highest predicted decile, while in the medical record model, the corresponding rates varied from 10% to 26%.
Variable | Percent | Estimate | Standard Error | Odds Ratio | 95% CI | |
---|---|---|---|---|---|---|
| ||||||
Age 65, mean (SD) | 15.24 (7.87) | 0.003 | 0.002 | 0.997 | 0.993 | 1.000 |
Male | 46.18 | 0.122 | 0.025 | 1.130 | 1.075 | 1.188 |
Nursing home resident | 17.71 | 0.035 | 0.037 | 1.036 | 0.963 | 1.114 |
Neoplastic disease | 6.80 | 0.130 | 0.049 | 1.139 | 1.034 | 1.254 |
Liver disease | 1.04 | 0.089 | 0.123 | 0.915 | 0.719 | 1.164 |
History of heart failure | 28.98 | 0.234 | 0.029 | 1.264 | 1.194 | 1.339 |
History of renal disease | 8.51 | 0.188 | 0.047 | 1.206 | 1.100 | 1.323 |
Altered mental status | 17.95 | 0.009 | 0.034 | 1.009 | 0.944 | 1.080 |
Pleural effusion | 21.20 | 0.165 | 0.030 | 1.179 | 1.111 | 1.251 |
BUN 30 mg/dl | 23.28 | 0.160 | 0.033 | 1.174 | 1.100 | 1.252 |
BUN missing | 14.56 | 0.101 | 0.185 | 0.904 | 0.630 | 1.298 |
Systolic BP <90 mmHg | 2.95 | 0.068 | 0.070 | 1.070 | 0.932 | 1.228 |
Systolic BP missing | 11.21 | 0.149 | 0.425 | 1.160 | 0.504 | 2.669 |
Pulse 125/min | 7.73 | 0.036 | 0.047 | 1.036 | 0.945 | 1.137 |
Pulse missing | 11.22 | 0.210 | 0.405 | 1.234 | 0.558 | 2.729 |
Respiratory rate 30/min | 16.38 | 0.079 | 0.034 | 1.082 | 1.012 | 1.157 |
Respiratory rate missing | 11.39 | 0.204 | 0.240 | 1.226 | 0.765 | 1.964 |
Sodium <130 mmol/L | 4.82 | 0.136 | 0.057 | 1.145 | 1.025 | 1.280 |
Sodium missing | 14.39 | 0.049 | 0.143 | 1.050 | 0.793 | 1.391 |
Glucose 250 mg/dl | 5.19 | 0.005 | 0.057 | 0.995 | 0.889 | 1.114 |
Glucose missing | 15.44 | 0.156 | 0.105 | 0.855 | 0.696 | 1.051 |
Hematocrit <30% | 7.77 | 0.270 | 0.044 | 1.310 | 1.202 | 1.428 |
Hematocrit missing | 13.62 | 0.071 | 0.135 | 0.932 | 0.715 | 1.215 |
Creatinine 2.5 mg/dL | 4.68 | 0.109 | 0.062 | 1.115 | 0.989 | 1.258 |
Creatinine missing | 14.63 | 0.200 | 0.167 | 1.221 | 0.880 | 1.695 |
WBC 6‐12 b/L | 38.04 | 0.021 | 0.049 | 0.979 | 0.889 | 1.079 |
WBC >12 b/L | 41.45 | 0.068 | 0.049 | 0.934 | 0.848 | 1.029 |
WBC missing | 12.85 | 0.167 | 0.162 | 1.181 | 0.860 | 1.623 |
Immunosuppressive therapy | 15.01 | 0.347 | 0.035 | 1.415 | 1.321 | 1.516 |
Chronic lung disease | 42.16 | 0.137 | 0.028 | 1.147 | 1.086 | 1.211 |
Coronary artery disease | 39.57 | 0.150 | 0.028 | 1.162 | 1.100 | 1.227 |
Diabetes mellitus | 20.90 | 0.137 | 0.033 | 1.147 | 1.076 | 1.223 |
Alcohol/drug abuse | 3.40 | 0.099 | 0.071 | 0.906 | 0.788 | 1.041 |
Dementia/Alzheimer's disease | 16.38 | 0.125 | 0.038 | 1.133 | 1.052 | 1.222 |
Splenectomy | 0.44 | 0.016 | 0.186 | 1.016 | 0.706 | 1.463 |
Model | Calibration (0, 1)* | Discrimination | Residuals Lack of Fit (Pearson Residual Fall %) | Model 2 (No. of Covariates) | ||||
---|---|---|---|---|---|---|---|---|
Predictive Ability (Lowest Decile, Highest Decile) | AUC | (<2) | (2, 0) | (0, 2) | (2+) | |||
| ||||||||
Medical Record Model Development Sample (NP) | ||||||||
N = 47,429 No. of 30‐day readmissions = 8,042 | (1, 0) | (0.10, 0.26) | 0.59 | 0 | 83.04 | 5.28 | 11.68 | 710 (35) |
Linked Administrative Model Validation Sample | ||||||||
N = 47,429 No. of 30‐day readmissions = 8,042 | (1, 0) | (0.08, 0.30) | 0.63 | 0 | 83.04 | 6.94 | 10.01 | 1,414 (40) |
The correlation coefficient of the estimated state‐specific standardized readmission rates from the administrative and medical record models was 0.96, and the proportion of the variance explained by the model was 0.92 (Figure 4).
DISCUSSION
We have described the development, validation, and results of a hospital, 30‐day, risk‐standardized readmission model for pneumonia that was created to support current federal transparency initiatives. The model uses administrative claims data from Medicare fee‐for‐service patients and produces results that are comparable to a model based on information obtained through manual abstraction of medical records. We observed an overall 30‐day readmission rate of 17%, and our analyses revealed substantial variation across US hospitals, suggesting that improvement by lower performing institutions is an achievable goal.
Because more than one in six pneumonia patients are rehospitalized shortly after discharge, and because pneumonia hospitalizations represent an enormous expense to the Medicare program, prevention of readmissions is now widely recognized to offer a substantial opportunity to improve patient outcomes while simultaneously lowering health care costs. Accordingly, promotion of strategies to reduce readmission rates has become a key priority for payers and quality‐improvement organizations. These range from policy‐level attempts to stimulate change, such as publicly reporting hospital readmission rates on government websites, to establishing accreditation standardssuch as the Joint Commission's requirement to accurately reconcile medications, to the creation of quality improvement collaboratives focused on sharing best practices across institutions. Regardless of the approach taken, a valid, risk‐adjusted measure of performance is required to evaluate and track performance over time. The measure we have described meets the National Quality Forum's measure evaluation criteria in that it addresses an important clinical topic for which there appears to be significant opportunities for improvement, the measure is precisely defined and has been subjected to validity and reliability testing, it is risk‐adjusted based on patient clinical factors present at the start of care, is feasible to produce, and is understandable by a broad range of potential users.21 Because hospitalists are the physicians primarily responsible for the care of patients with pneumonia at US hospitals, and because they frequently serve as the physician champions for quality improvement activities related to pneumonia, it is especially important that they maintain a thorough understanding of the measures and methodologies underlying current efforts to measure hospital performance.
Several features of our approach warrant additional comment. First, we deliberately chose to measure all readmission events rather than attempt to discriminate between potentially preventable and nonpreventable readmissions. From the patient perspective, readmission for any reason is a concern, and limiting the measure to pneumonia‐related readmissions could make it susceptible to gaming by hospitals. Moreover, determining whether a readmission is related to a potential quality problem is not straightforward. For example, a patient with pneumonia whose discharge medications were prescribed incorrectly may be readmitted with a hip fracture following an episode of syncope. It would be inappropriate to treat this readmission as unrelated to the care the patient received for pneumonia. Additionally, while our approach does not presume that every readmission is preventable, the goal is to reduce the risk of readmissions generally (not just in narrowly defined subpopulations), and successful interventions to reduce rehospitalization have typically demonstrated reductions in all‐cause readmission.9, 22 Second, deaths that occurred within 30 days of discharge, yet that were not accompanied by a hospital readmission, were not counted as a readmission outcome. While it may seem inappropriate to treat a postdischarge death as a nonevent (rather than censoring or excluding such cases), alternative analytic approaches, such as using a hierarchical survival model, are not currently computationally feasible with large national data sets. Fortunately, only a relatively small proportion of discharges fell into this category (5.2% of index cases in the 2006 development sample died within 30 days of discharge without being readmitted). An alternative approach to handling the competing outcome of death would have been to use a composite outcome of readmission or death. However, we believe that it is important to report the outcomes separately because factors that predict readmission and mortality may differ, and when making comparisons across hospitals it would not be possible to determine whether differences in rate were due to readmission or mortality. Third, while the patient‐level readmission model showed only modest discrimination, we intentionally excluded covariates such as race and socioeconomic status, as well as in‐hospital events and potential complications of care, and whether patients were discharged home or to a skilled nursing facility. While these variables could have improved predictive ability, they may be directly or indirectly related to quality or supply factors that should not be included in a model that seeks to control for patient clinical characteristics. For example, if hospitals with a large share of poor patients have higher readmission rates, then including income in the model will obscure differences that are important to identify. While we believe that the decision to exclude such factors in the model is in the best interest of patients, and supports efforts to reduce health inequality in society more generally, we also recognize that hospitals that care for a disproportionate share of poor patients are likely to require additional resources to overcome these social factors. Fourth, we limited the analysis to patients with a principal diagnosis of pneumonia, and chose not to also include those with a principal diagnosis of sepsis or respiratory failure coupled with a secondary diagnosis of pneumonia. While the broader definition is used by CMS in the National Pneumonia Project, that initiative relied on chart abstraction to differentiate pneumonia present at the time of admission from cases developing as a complication of hospitalization. Additionally, we did not attempt to differentiate between community‐acquired and healthcare‐associated pneumonia, however our approach is consistent with the National Pneumonia Project and Pneumonia Patient Outcomes Research Team.18 Fifth, while our model estimates readmission rates at the hospital level, we recognize that readmissions are influenced by a complex and extensive range of factors. In this context, greater cooperation between hospitals and other care providers will almost certainly be required in order to achieve dramatic improvement in readmission rates, which in turn will depend upon changes to the way serious illness is paid for. Some options that have recently been described include imposing financial penalties for early readmission, extending the boundaries of case‐based payment beyond hospital discharge, and bundling payments between hospitals and physicians.2325
Our measure has several limitations. First, our models were developed and validated using Medicare data, and the results may not apply to pneumonia patients less than 65 years of age. However, most patients hospitalized with pneumonia in the US are 65 or older. In addition, we were unable to test the model with a Medicare managed care population, because data are not currently available on such patients. Finally, the medical record‐based validation was conducted by state‐level analysis because the sample size was insufficient to carry this out at the hospital level.
In conclusion, more than 17% of Medicare beneficiaries are readmitted within 30 days following discharge after a hospitalization for pneumonia, and rates vary substantially across institutions. The development of a valid measure of hospital performance and public reporting are important first steps towards focusing attention on this problem. Actual improvement will now depend on whether hospitals and partner organizations are successful at identifying and implementing effective methods to prevent readmission.
- Rehospitalizations among patients in the Medicare Fee‐for‐Service Program.N Engl J Med.2009;360(14):1418–1428. , , .
- Medicare Payment Advisory Commission.Report to the Congress: Promoting Greater Efficiency in Medicare.2007.
- 2009. Available at: http://www.hcup‐us.ahrq.gov/reports.jsp. Accessed November 7, 2009. , , , , . HCUP Facts and Figures: Statistics on Hospital‐based Care in the United States, 2007.
- Centers for Medicare 353(3):255–264.
- Trends in postdischarge mortality and readmissions: has length of stay declined too far?Arch Intern Med.2004;164(5):538–544. , , , .
- Short‐term outcomes and their predictors for patients hospitalized with community‐acquired pneumonia.Heart Lung.2004;33(5):301–307. , , , .
- Improved clinical outcomes with utilization of a community‐acquired pneumonia guideline.Chest.2006;130(3):794–799. , , , et al.
- Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia.Arch Intern Med.1999;159(21):2562–2572. , , , , .
- Hospital readmissions as a measure of quality of health care: advantages and limitations.Arch Intern Med.2000;160(8):1074–1081. , .
- The care transitions intervention: results of a randomized controlled trial.Arch Intern Med.2006;166(17):1822–1828. , , , .
- Corrigan JM, Eden J, Smith BM, eds.Leadership by Example: Coordinating Government Roles in Improving Health Care Quality. Committee on Enhancing Federal Healthcare Quality Programs.Washington, DC:National Academies Press,2003.
- Medicare.gov—Hospital Compare. Available at: http://www.hospitalcompare.hhs.gov/Hospital/Search/Welcome.asp?version=default1(1):29–37.
- Measuring performance for treating heart attacks and heart failure: the case for outcomes measurement.Health Aff.2007;26(1):75–85. , , , , .
- NQF‐Endorsed® Standards. Available at: http://www.qualityforum.org/Measures_List.aspx. Accessed November 6,2009.
- Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community‐acquired pneumonia.Arch Intern Med.2004;164(6):637–644. , , , , .
- 2000. Available at: http://www.cms.hhs.gov/Reports/Reports/ItemDetail.asp?ItemID=CMS023176. Accessed November 7, 2009. , , . Diagnostic Cost Group Hierarchical Condition Category Models for Medicare Risk Adjustment. Report prepared for the Health Care Financing Administration. Health Economics Research, Inc;
- Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis.1st ed.New York:Springer;2006. .
- National Quality Forum—Measure Evaluation Criteria.2008. Available at: http://www.qualityforum.org/uploadedFiles/Quality_Forum/Measuring_Performance/Consensus_Development_Process%E2%80%99s_Principle/EvalCriteria2008–08‐28Final.pdf?n=4701.
- Comprehensive discharge planning and home follow‐up of hospitalized elders: a randomized clinical trial.JAMA.1999;281(7):613–620. , , , et al.
- Paying for care episodes and care coordination.N Engl J Med.2007;356(11):1166–1168. .
- Health care reform—toward more freedom, and responsibility, for physicians.N Engl J Med.2009;361(6):623–628. .
- Beyond pay for performance—emerging models of provider‐payment reform.N Engl J Med.2008;359(12):1197–1200. .
- Rehospitalizations among patients in the Medicare Fee‐for‐Service Program.N Engl J Med.2009;360(14):1418–1428. , , .
- Medicare Payment Advisory Commission.Report to the Congress: Promoting Greater Efficiency in Medicare.2007.
- 2009. Available at: http://www.hcup‐us.ahrq.gov/reports.jsp. Accessed November 7, 2009. , , , , . HCUP Facts and Figures: Statistics on Hospital‐based Care in the United States, 2007.
- Centers for Medicare 353(3):255–264.
- Trends in postdischarge mortality and readmissions: has length of stay declined too far?Arch Intern Med.2004;164(5):538–544. , , , .
- Short‐term outcomes and their predictors for patients hospitalized with community‐acquired pneumonia.Heart Lung.2004;33(5):301–307. , , , .
- Improved clinical outcomes with utilization of a community‐acquired pneumonia guideline.Chest.2006;130(3):794–799. , , , et al.
- Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia.Arch Intern Med.1999;159(21):2562–2572. , , , , .
- Hospital readmissions as a measure of quality of health care: advantages and limitations.Arch Intern Med.2000;160(8):1074–1081. , .
- The care transitions intervention: results of a randomized controlled trial.Arch Intern Med.2006;166(17):1822–1828. , , , .
- Corrigan JM, Eden J, Smith BM, eds.Leadership by Example: Coordinating Government Roles in Improving Health Care Quality. Committee on Enhancing Federal Healthcare Quality Programs.Washington, DC:National Academies Press,2003.
- Medicare.gov—Hospital Compare. Available at: http://www.hospitalcompare.hhs.gov/Hospital/Search/Welcome.asp?version=default1(1):29–37.
- Measuring performance for treating heart attacks and heart failure: the case for outcomes measurement.Health Aff.2007;26(1):75–85. , , , , .
- NQF‐Endorsed® Standards. Available at: http://www.qualityforum.org/Measures_List.aspx. Accessed November 6,2009.
- Timing of antibiotic administration and outcomes for Medicare patients hospitalized with community‐acquired pneumonia.Arch Intern Med.2004;164(6):637–644. , , , , .
- 2000. Available at: http://www.cms.hhs.gov/Reports/Reports/ItemDetail.asp?ItemID=CMS023176. Accessed November 7, 2009. , , . Diagnostic Cost Group Hierarchical Condition Category Models for Medicare Risk Adjustment. Report prepared for the Health Care Financing Administration. Health Economics Research, Inc;
- Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis.1st ed.New York:Springer;2006. .
- National Quality Forum—Measure Evaluation Criteria.2008. Available at: http://www.qualityforum.org/uploadedFiles/Quality_Forum/Measuring_Performance/Consensus_Development_Process%E2%80%99s_Principle/EvalCriteria2008–08‐28Final.pdf?n=4701.
- Comprehensive discharge planning and home follow‐up of hospitalized elders: a randomized clinical trial.JAMA.1999;281(7):613–620. , , , et al.
- Paying for care episodes and care coordination.N Engl J Med.2007;356(11):1166–1168. .
- Health care reform—toward more freedom, and responsibility, for physicians.N Engl J Med.2009;361(6):623–628. .
- Beyond pay for performance—emerging models of provider‐payment reform.N Engl J Med.2008;359(12):1197–1200. .
Copyright © 2010 Society of Hospital Medicine
Readmission and Mortality [Rates] in Pneumonia
Pneumonia results in some 1.2 million hospital admissions each year in the United States, is the second leading cause of hospitalization among patients over 65, and accounts for more than $10 billion annually in hospital expenditures.1, 2 As a result of complex demographic and clinical forces, including an aging population, increasing prevalence of comorbidities, and changes in antimicrobial resistance patterns, between the periods 1988 to 1990 and 2000 to 2002 the number of patients hospitalized for pneumonia grew by 20%, and pneumonia was the leading infectious cause of death.3, 4
Given its public health significance, pneumonia has been the subject of intensive quality measurement and improvement efforts for well over a decade. Two of the largest initiatives are the Centers for Medicare & Medicaid Services (CMS) National Pneumonia Project and The Joint Commission ORYX program.5, 6 These efforts have largely entailed measuring hospital performance on pneumonia‐specific processes of care, such as whether blood oxygen levels were assessed, whether blood cultures were drawn before antibiotic treatment was initiated, the choice and timing of antibiotics, and smoking cessation counseling and vaccination at the time of discharge. While measuring processes of care (especially when they are based on sound evidence), can provide insights about quality, and can help guide hospital improvement efforts, these measures necessarily focus on a narrow spectrum of the overall care provided. Outcomes can complement process measures by directing attention to the results of care, which are influenced by both measured and unmeasured factors, and which may be more relevant from the patient's perspective.79
In 2008 CMS expanded its public reporting initiatives by adding risk‐standardized hospital mortality rates for pneumonia to the Hospital Compare website (
Methods
Design, Setting, Subjects
We conducted a cross‐sectional study at the hospital level of the outcomes of care of fee‐for‐service patients hospitalized for pneumonia between July 2006 and June 2009. Patients are eligible to be included in the measures if they are 65 years or older, have a principal diagnosis of pneumonia (International Classification of Diseases, Ninth Revision, Clinical Modification codes 480.X, 481, 482.XX, 483.X, 485, 486, and 487.0), and are cared for at a nonfederal acute care hospital in the US and its organized territories, including Puerto Rico, Guam, the US Virgin Islands, and the Northern Mariana Islands.
The mortality measure excludes patients enrolled in the Medicare hospice program in the year prior to, or on the day of admission, those in whom pneumonia is listed as a secondary diagnosis (to eliminate cases resulting from complications of hospitalization), those discharged against medical advice, and patients who are discharged alive but whose length of stay in the hospital is less than 1 day (because of concerns about the accuracy of the pneumonia diagnosis). Patients are also excluded if their administrative records for the period of analysis (1 year prior to hospitalization and 30 days following discharge) were not available or were incomplete, because these are needed to assess comorbid illness and outcomes. The readmission measure is similar, but does not exclude patients on the basis of hospice program enrollment (because these patients have been admitted and readmissions for hospice patients are likely unplanned events that can be measured and reduced), nor on the basis of hospital length of stay (because patients discharged within 24 hours may be at a heightened risk of readmission).11, 12
Information about patient comorbidities is derived from diagnoses recorded in the year prior to the index hospitalization as found in Medicare inpatient, outpatient, and carrier (physician) standard analytic files. Comorbidities are identified using the Condition Categories of the Hierarchical Condition Category grouper, which sorts the more than 15,000 possible diagnostic codes into 189 clinically‐coherent conditions and which was originally developed to support risk‐adjusted payments within Medicare managed care.13
Outcomes
The patient outcomes assessed include death from any cause within 30 days of admission and readmission for any cause within 30 days of discharge. All‐cause, rather than disease‐specific, readmission was chosen because hospital readmission as a consequence of suboptimal inpatient care or discharge coordination may manifest in many different diagnoses, and no validated method is available to distinguish related from unrelated readmissions. The measures use the Medicare Enrollment Database to determine mortality status, and acute care hospital inpatient claims are used to identify readmission events. For patients with multiple hospitalizations during the study period, the mortality measure randomly selects one hospitalization to use for determination of mortality. Admissions that are counted as readmissions (i.e., those that occurred within 30 days of discharge following hospitalization for pneumonia) are not also treated as index hospitalizations. In the case of patients who are transferred to or from another acute care facility, responsibility for deaths is assigned to the hospital that initially admitted the patient, while responsibility for readmissions is assigned to the hospital that ultimately discharges the patient to a nonacute setting (e.g., home, skilled nursing facilities).
Risk‐Standardization Methods
Hierarchical logistic regression is used to model the log‐odds of mortality or readmission within 30 days of admission or discharge from an index pneumonia admission as a function of patient demographic and clinical characteristics and a random hospital‐specific intercept. This strategy accounts for within‐hospital correlation of the observed outcomes, and reflects the assumption that underlying differences in quality among the hospitals being evaluated lead to systematic differences in outcomes. In contrast to nonhierarchical models which ignore hospital effects, this method attempts to measure the influence of the hospital on patient outcome after adjusting for patient characteristics. Comorbidities from the index admission that could represent potential complications of care are not included in the model unless they are also documented in the 12 months prior to admission. Hospital‐specific mortality and readmission rates are calculated as the ratio of predicted‐to‐expected events (similar to the observed/expected ratio), multiplied by the national unadjusted rate, a form of indirect standardization.
The model for mortality has a c‐statistic of 0.72 whereas a model based on medical record review that was developed for validation purposes had a c‐statistic of 0.77. The model for readmission has a c‐statistic of 0.63 whereas a model based on medical review had a c‐statistic of 0.59. The mortality and readmission models produce similar state‐level mortality and readmission rate estimates as the models derived from medical record review, and can therefore serve as reasonable surrogates. These methods, including their development and validation, have been described fully elsewhere,14, 15 and have been evaluated and subsequently endorsed by the National Quality Forum.16
Identification of Geographic Regions
To characterize patterns of performance geographically we identified the 306 hospital referral regions for each hospital in our analysis using definitions provided by the Dartmouth Atlas of Health Care project. Unlike a hospital‐level analysis, the hospital referral regions represent regional markets for tertiary care and are widely used to summarize variation in medical care inputs, utilization patterns, and health outcomes and provide a more detailed look at variation in outcomes than results at the state level.17
Analyses
Summary statistics were constructed using frequencies and proportions for categorical data, and means, medians and interquartile ranges for continuous variables. To characterize 30‐day risk‐standardized mortality and readmission rates at the hospital‐referral region level, we calculated means and percentiles by weighting each hospital's value by the inverse of the variance of the hospital's estimated rate. Hospitals with larger sample sizes, and therefore more precise estimates, lend more weight to the average. Hierarchical models were estimated using the SAS GLIMMIX procedure. Bayesian shrinkage was used to estimate rates in order to take into account the greater uncertainty in the true rates of hospitals with small caseloads. Using this technique, estimated rates at low volume institutions are shrunken toward the population mean, while hospitals with large caseloads have a relatively smaller amount of shrinkage and the estimate is closer to the hospital's observed rate.18
To determine whether a hospital's performance is significantly different than the national rate we measured whether the 95% interval estimate for the risk‐standardized rate overlapped with the national crude mortality or readmission rate. This information is used to categorize hospitals on Hospital Compare as better than the US national rate, worse than the US national rate, or no different than the US national rate. Hospitals with fewer than 25 cases in the 3‐year period, are excluded from this categorization on Hospital Compare.
Analyses were conducted with the use of SAS 9.1.3 (SAS Institute Inc, Cary, NC). We created the hospital referral region maps using ArcGIS version 9.3 (ESRI, Redlands, CA). The Human Investigation Committee at the Yale School of Medicine approved an exemption for the authors to use CMS claims and enrollment data for research analyses and publication.
Results
Hospital‐Specific Risk‐Standardized 30‐Day Mortality and Readmission Rates
Of the 1,118,583 patients included in the mortality analysis 129,444 (11.6%) died within 30 days of hospital admission. The median (Q1, Q3) hospital 30‐day risk‐standardized mortality rate was 11.1% (10.0%, 12.3%), and ranged from 6.7% to 20.9% (Table 1, Figure 1). Hospitals at the 10th percentile had 30‐day risk‐standardized mortality rates of 9.0% while for those at the 90th percentile of performance the rate was 13.5%. The odds of all‐cause mortality for a patient treated at a hospital that was one standard deviation above the national average was 1.68 times higher than that of a patient treated at a hospital that was one standard deviation below the national average.
Mortality | Readmission | |
---|---|---|
| ||
Patients (n) | 1118583 | 1161817 |
Hospitals (n) | 4788 | 4813 |
Patient age, years, median (Q1, Q3) | 81 (74,86) | 80 (74,86) |
Nonwhite, % | 11.1 | 11.1 |
Hospital case volume, median (Q1, Q3) | 168 (77,323) | 174 (79,334) |
Risk‐standardized hospital rate, mean (SD) | 11.2 (1.2) | 18.3 (0.9) |
Minimum | 6.7 | 13.6 |
1st percentile | 7.5 | 14.9 |
5th percentile | 8.5 | 15.8 |
10th percentile | 9.0 | 16.4 |
25th percentile | 10.0 | 17.2 |
Median | 11.1 | 18.2 |
75th percentile | 12.3 | 19.2 |
90th percentile | 13.5 | 20.4 |
95th percentile | 14.4 | 21.1 |
99th percentile | 16.1 | 22.8 |
Maximum | 20.9 | 26.7 |
Model fit statistics | ||
c‐Statistic | 0.72 | 0.63 |
Intrahospital Correlation | 0.07 | 0.03 |
For the 3‐year period 2006 to 2009, 222 (4.7%) hospitals were categorized as having a mortality rate that was better than the national average, 3968 (83.7%) were no different than the national average, 221 (4.6%) were worse and 332 (7.0%) did not meet the minimum case threshold.
Among the 1,161,817 patients included in the readmission analysis 212,638 (18.3%) were readmitted within 30 days of hospital discharge. The median (Q1,Q3) 30‐day risk‐standardized readmission rate was 18.2% (17.2%, 19.2%) and ranged from 13.6% to 26.7% (Table 1, Figure 2). Hospitals at the 10th percentile had 30‐day risk‐standardized readmission rates of 16.4% while for those at the 90th percentile of performance the rate was 20.4%. The odds of all‐cause readmission for a patient treated at a hospital that was one standard deviation above the national average was 1.40 times higher than the odds of all‐cause readmission if treated at a hospital that was one standard deviation below the national average.
For the 3‐year period 2006 to 2009, 64 (1.3%) hospitals were categorized as having a readmission rate that was better than the national average, 4203 (88.2%) were no different than the national average, 163 (3.4%) were worse and 333 (7.0%) had less than 25 cases and were therefore not categorized.
While risk‐standardized readmission rates were substantially higher than risk‐standardized mortality rates, mortality rates varied more. For example, the top 10% of hospitals had a relative mortality rate that was 33% lower than those in the bottom 10%, as compared with just a 20% relative difference for readmission rates. The coefficient of variation, a normalized measure of dispersion that unlike the standard deviation is independent of the population mean, was 10.7 for risk‐standardized mortality rates and 4.9 for readmission rates.
Regional Risk‐Standardized 30‐Day Mortality and Readmission Rates
Figures 3 and 4 show the distribution of 30‐day risk‐standardized mortality and readmission rates among hospital referral regions by quintile. Highest mortality regions were found across the entire country, including parts of Northern New England, the Mid and South Atlantic, East and the West South Central, East and West North Central, and the Mountain and Pacific regions of the West. The lowest mortality rates were observed in Southern New England, parts of the Mid and South Atlantic, East and West South Central, and parts of the Mountain and Pacific regions of the West (Figure 3).
Readmission rates were higher in the eastern portions of the US (including the Northeast, Mid and South Atlantic, East South Central) as well as the East North Central, and small parts of the West North Central portions of the Midwest and in Central California. The lowest readmission rates were observed in the West (Mountain and Pacific regions), parts of the Midwest (East and West North Central) and small pockets within the South and Northeast (Figure 4).
Discussion
In this 3‐year analysis of patient, hospital, and regional outcomes we observed that pneumonia in the elderly remains a highly morbid illness, with a 30‐day mortality rate of approximately 11.6%. More notably we observed that risk‐standardized mortality rates, and to a lesser extent readmission rates, vary significantly across hospitals and regions. Finally, we observed that readmission rates, but not mortality rates, show strong geographic concentration.
These findings suggest possible opportunities to save or extend the lives of a substantial number of Americans, and to reduce the burden of rehospitalization on patients and families, if low performing institutions were able to achieve the performance of those with better outcomes. Additionally, because readmission is so common (nearly 1 in 5 patients), efforts to reduce overall health care spending should focus on this large potential source of savings.19 In this regard, impending changes in payment to hospitals around readmissions will change incentives for hospitals and physicians that may ultimately lead to lower readmission rates.20
Previous analyses of the quality of hospital care for patients with pneumonia have focused on the percentage of eligible patients who received guideline‐recommended antibiotics within a specified time frame (4 or 8 hours), and vaccination prior to hospital discharge.21, 22 These studies have highlighted large differences across hospitals and states in the percentage receiving recommended care. In contrast, the focus of this study was to compare risk‐standardized outcomes of care at the nation's hospitals and across its regions. This effort was guided by the notion that the measurement of care outcomes is an important complement to process measurement because outcomes represent a more holistic assessment of care, that an outcomes focus offers hospitals greater autonomy in terms of what processes to improve, and that outcomes are ultimately more meaningful to patients than the technical aspects of how the outcomes were achieved. In contrast to these earlier process‐oriented efforts, the magnitude of the differences we observed in mortality and readmission rates across hospitals was not nearly as large.
A recent analysis of the outcomes of care for patients with heart failure and acute myocardial infarction also found significant variation in both hospital and regional mortality and readmission rates.23 The relative differences in risk‐standardized hospital mortality rates across the 10th to 90th percentiles of hospital performance was 25% for acute myocardial infarction, and 39% for heart failure. By contrast, we found that the difference in risk‐standardized hospital mortality rates across the 10th to 90th percentiles in pneumonia was an even greater 50% (13.5% vs. 9.0%). Similar to the findings in acute myocardial infarction and heart failure, we observed that risk‐standardized mortality rates varied more so than did readmission rates.
Our study has a number of limitations. First, the analysis was restricted to Medicare patients only, and our findings may not be generalizable to younger patients. Second, our risk‐adjustment methods relied on claims data, not clinical information abstracted from charts. Nevertheless, we assessed comorbidities using all physician and hospital claims from the year prior to the index admission. Additionally our mortality and readmission models were validated against those based on medical record data and the outputs of the 2 approaches were highly correlated.15, 24, 25 Our study was restricted to patients with a principal diagnosis of pneumonia, and we therefore did not include those whose principal diagnosis was sepsis or respiratory failure and who had a secondary diagnosis of pneumonia. While this decision was made to reduce the risk of misclassifying complications of care as the reason for admission, we acknowledge that this is likely to have limited our study to patients with less severe disease, and may have introduced bias related to differences in hospital coding practices regarding the use of sepsis and respiratory failure codes. While we excluded patients with 1 day length of stay from the mortality analysis to reduce the risk of including patients in the measure who did not actually have pneumonia, we did not exclude them from the readmission analysis because very short length of stay may be a risk factor for readmission. An additional limitation of our study is that our findings are primarily descriptive, and we did not attempt to explain the sources of the variation we observed. For example, we did not examine the extent to which these differences might be explained by differences in adherence to process measures across hospitals or regions. However, if the experience in acute myocardial infarction can serve as a guide, then it is unlikely that more than a small fraction of the observed variation in outcomes can be attributed to factors such as antibiotic timing or selection.26 Additionally, we cannot explain why readmission rates were more geographically distributed than mortality rates, however it is possible that this may be related to the supply of physicians or hospital beds.27 Finally, some have argued that mortality and readmission rates do not necessarily reflect the very quality they intend to measure.2830
The outcomes of patients with pneumonia appear to be significantly influenced by both the hospital and region where they receive care. Efforts to improve population level outcomes might be informed by studying the practices of hospitals and regions that consistently achieve high levels of performance.31
Acknowledgements
The authors thank Sandi Nelson, Eric Schone, and Marian Wrobel at Mathematicia Policy Research and Changquin Wang and Jinghong Gao at YNHHS/Yale CORE for analytic support. They also acknowledge Shantal Savage, Kanchana Bhat, and Mayur M. Desai at Yale, Joseph S. Ross at the Mount Sinai School of Medicine, and Shaheen Halim at the Centers for Medicare and Medicaid Services.
- http://www.hcup‐us.ahrq.gov/reports.jsp. Accessed June2010. , , , , . HCUP Facts and Figures: Statistics on Hospital‐based Care in the United States, 2007 [Internet]. 2009 [cited 2009 Nov 7]. Available at:
- Agency for Healthcare Research and Quality. HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). [Internet]. 2007 [cited 2010 May 13]. Available at: http://www.hcup‐us.ahrq.gov/nisoverview.jsp. Accessed June2010.
- Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988‐2002.JAMA.20057;294(21):2712–2719. , , , , .
- http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_ 14.pdf. Accessed June2010. . Deaths: Leading Causes for 2006. NVSS [Internet]. 2010 Mar 31;58(14). Available at:
- Centers for Medicare and Medicaid Services. Pneumonia [Internet]. [cited 2010 May 13]. Available at: http://www.qualitynet.org/dcs/ContentServer?cid= 108981596702326(1):75–85.
- Performance measures for pneumonia: are they valuable, and are process measures adequate?Curr Opin Infect Dis.2007;20(2):182–189. , , .
- Relationship Between Medicare's Hospital Compare Performance Measures and Mortality Rates.JAMA.2006;296(22):2694–2702. , .
- Medicare.gov ‐ Hospital Compare [Internet]. [cited 2009 Nov 6]. Available at: http://www.hospitalcompare.hhs.gov/Hospital/Search/Welcome.asp? version=default 2010. Available at: http://www.qualitynet.org/dcs/ContentServer? c=Page 2010. Available at: http://www.qualitynet.org/dcs/ContentServer? c=Page 2000 [cited 2009 Nov 7]. Available at: http://www.cms.hhs.gov/Reports/Reports/ItemDetail.asp?ItemID=CMS023176. Accessed June2010.
- http://www.qualitynet.org/dcs/ContentServer?c= Page 2008. Available at: http://www.qualitynet.org/dcs/ContentServer?c= Page1999. , , , et al. Risk‐Adjustment Methodology for Hospital Monitoring/Surveillance and Public Reporting Supplement #1: 30‐Day Mortality Model for Pneumonia [Internet]. Yale University; 2006. Available at:
- Statistical and clinical aspects of hospital outcomes profiling.Stat Sci.2007;22(2):206–226. , .
- Medicare Payment Advisory Commission. Report to the Congress: Promoting Greater Efficiency in Medicare.2007 June.
- Patient Protection and Affordable Care Act [Internet]. 2010. Available at: http://thomas.loc.gov. Accessed June2010.
- Quality of medical care delivered to medicare beneficiaries: a profile at state and national levels.JAMA.2000;284(13):1670–1676. , , , et al.
- Care in U.S. hospitals — the hospital quality alliance program.N Engl J Med.2005;353(3):265–274. , , , .
- Patterns of hospital performance in acute myocardial infarction and heart failure 30‐day mortality and readmission.Circ Cardiovasc Qual Outcomes.2009;2(5):407–413. , , , et al.
- An administrative claims model suitable for profiling hospital performance based on 30‐day mortality rates among patients with heart failure.Circulation.2006;113(13):1693–1701. , , , et al.
- An administrative claims model suitable for profiling hospital performance based on 30‐day mortality rates among patients with an acute myocardial infarction.Circulation.2006;113(13):1683–1692. , , , et al.
- Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short‐term mortality.JAMA.2006;296(1):72–78. , , , et al.
- Hospital readmission rates for cohorts of medicare beneficiaries in Boston and New Haven.N Engl J Med.1994;331(15):989–995. , , , .
- Research evidence on the validity of risk‐adjusted mortality rate as a measure of hospital quality of care.Med Care Res Rev.1998;55(4):371–404. , .
- Hospital readmissions as a measure of quality of health care: advantages and limitations.Arch Intern Med.2000;160(8):1074–1081. , .
- Hospital mortality: when failure is not a good measure of success.CMAJ.2008;179(2):153–157. , .
- Research in action: using positive deviance to improve quality of health care.Implement Sci.2009;4:25. , , , , , .
Pneumonia results in some 1.2 million hospital admissions each year in the United States, is the second leading cause of hospitalization among patients over 65, and accounts for more than $10 billion annually in hospital expenditures.1, 2 As a result of complex demographic and clinical forces, including an aging population, increasing prevalence of comorbidities, and changes in antimicrobial resistance patterns, between the periods 1988 to 1990 and 2000 to 2002 the number of patients hospitalized for pneumonia grew by 20%, and pneumonia was the leading infectious cause of death.3, 4
Given its public health significance, pneumonia has been the subject of intensive quality measurement and improvement efforts for well over a decade. Two of the largest initiatives are the Centers for Medicare & Medicaid Services (CMS) National Pneumonia Project and The Joint Commission ORYX program.5, 6 These efforts have largely entailed measuring hospital performance on pneumonia‐specific processes of care, such as whether blood oxygen levels were assessed, whether blood cultures were drawn before antibiotic treatment was initiated, the choice and timing of antibiotics, and smoking cessation counseling and vaccination at the time of discharge. While measuring processes of care (especially when they are based on sound evidence), can provide insights about quality, and can help guide hospital improvement efforts, these measures necessarily focus on a narrow spectrum of the overall care provided. Outcomes can complement process measures by directing attention to the results of care, which are influenced by both measured and unmeasured factors, and which may be more relevant from the patient's perspective.79
In 2008 CMS expanded its public reporting initiatives by adding risk‐standardized hospital mortality rates for pneumonia to the Hospital Compare website (
Methods
Design, Setting, Subjects
We conducted a cross‐sectional study at the hospital level of the outcomes of care of fee‐for‐service patients hospitalized for pneumonia between July 2006 and June 2009. Patients are eligible to be included in the measures if they are 65 years or older, have a principal diagnosis of pneumonia (International Classification of Diseases, Ninth Revision, Clinical Modification codes 480.X, 481, 482.XX, 483.X, 485, 486, and 487.0), and are cared for at a nonfederal acute care hospital in the US and its organized territories, including Puerto Rico, Guam, the US Virgin Islands, and the Northern Mariana Islands.
The mortality measure excludes patients enrolled in the Medicare hospice program in the year prior to, or on the day of admission, those in whom pneumonia is listed as a secondary diagnosis (to eliminate cases resulting from complications of hospitalization), those discharged against medical advice, and patients who are discharged alive but whose length of stay in the hospital is less than 1 day (because of concerns about the accuracy of the pneumonia diagnosis). Patients are also excluded if their administrative records for the period of analysis (1 year prior to hospitalization and 30 days following discharge) were not available or were incomplete, because these are needed to assess comorbid illness and outcomes. The readmission measure is similar, but does not exclude patients on the basis of hospice program enrollment (because these patients have been admitted and readmissions for hospice patients are likely unplanned events that can be measured and reduced), nor on the basis of hospital length of stay (because patients discharged within 24 hours may be at a heightened risk of readmission).11, 12
Information about patient comorbidities is derived from diagnoses recorded in the year prior to the index hospitalization as found in Medicare inpatient, outpatient, and carrier (physician) standard analytic files. Comorbidities are identified using the Condition Categories of the Hierarchical Condition Category grouper, which sorts the more than 15,000 possible diagnostic codes into 189 clinically‐coherent conditions and which was originally developed to support risk‐adjusted payments within Medicare managed care.13
Outcomes
The patient outcomes assessed include death from any cause within 30 days of admission and readmission for any cause within 30 days of discharge. All‐cause, rather than disease‐specific, readmission was chosen because hospital readmission as a consequence of suboptimal inpatient care or discharge coordination may manifest in many different diagnoses, and no validated method is available to distinguish related from unrelated readmissions. The measures use the Medicare Enrollment Database to determine mortality status, and acute care hospital inpatient claims are used to identify readmission events. For patients with multiple hospitalizations during the study period, the mortality measure randomly selects one hospitalization to use for determination of mortality. Admissions that are counted as readmissions (i.e., those that occurred within 30 days of discharge following hospitalization for pneumonia) are not also treated as index hospitalizations. In the case of patients who are transferred to or from another acute care facility, responsibility for deaths is assigned to the hospital that initially admitted the patient, while responsibility for readmissions is assigned to the hospital that ultimately discharges the patient to a nonacute setting (e.g., home, skilled nursing facilities).
Risk‐Standardization Methods
Hierarchical logistic regression is used to model the log‐odds of mortality or readmission within 30 days of admission or discharge from an index pneumonia admission as a function of patient demographic and clinical characteristics and a random hospital‐specific intercept. This strategy accounts for within‐hospital correlation of the observed outcomes, and reflects the assumption that underlying differences in quality among the hospitals being evaluated lead to systematic differences in outcomes. In contrast to nonhierarchical models which ignore hospital effects, this method attempts to measure the influence of the hospital on patient outcome after adjusting for patient characteristics. Comorbidities from the index admission that could represent potential complications of care are not included in the model unless they are also documented in the 12 months prior to admission. Hospital‐specific mortality and readmission rates are calculated as the ratio of predicted‐to‐expected events (similar to the observed/expected ratio), multiplied by the national unadjusted rate, a form of indirect standardization.
The model for mortality has a c‐statistic of 0.72 whereas a model based on medical record review that was developed for validation purposes had a c‐statistic of 0.77. The model for readmission has a c‐statistic of 0.63 whereas a model based on medical review had a c‐statistic of 0.59. The mortality and readmission models produce similar state‐level mortality and readmission rate estimates as the models derived from medical record review, and can therefore serve as reasonable surrogates. These methods, including their development and validation, have been described fully elsewhere,14, 15 and have been evaluated and subsequently endorsed by the National Quality Forum.16
Identification of Geographic Regions
To characterize patterns of performance geographically we identified the 306 hospital referral regions for each hospital in our analysis using definitions provided by the Dartmouth Atlas of Health Care project. Unlike a hospital‐level analysis, the hospital referral regions represent regional markets for tertiary care and are widely used to summarize variation in medical care inputs, utilization patterns, and health outcomes and provide a more detailed look at variation in outcomes than results at the state level.17
Analyses
Summary statistics were constructed using frequencies and proportions for categorical data, and means, medians and interquartile ranges for continuous variables. To characterize 30‐day risk‐standardized mortality and readmission rates at the hospital‐referral region level, we calculated means and percentiles by weighting each hospital's value by the inverse of the variance of the hospital's estimated rate. Hospitals with larger sample sizes, and therefore more precise estimates, lend more weight to the average. Hierarchical models were estimated using the SAS GLIMMIX procedure. Bayesian shrinkage was used to estimate rates in order to take into account the greater uncertainty in the true rates of hospitals with small caseloads. Using this technique, estimated rates at low volume institutions are shrunken toward the population mean, while hospitals with large caseloads have a relatively smaller amount of shrinkage and the estimate is closer to the hospital's observed rate.18
To determine whether a hospital's performance is significantly different than the national rate we measured whether the 95% interval estimate for the risk‐standardized rate overlapped with the national crude mortality or readmission rate. This information is used to categorize hospitals on Hospital Compare as better than the US national rate, worse than the US national rate, or no different than the US national rate. Hospitals with fewer than 25 cases in the 3‐year period, are excluded from this categorization on Hospital Compare.
Analyses were conducted with the use of SAS 9.1.3 (SAS Institute Inc, Cary, NC). We created the hospital referral region maps using ArcGIS version 9.3 (ESRI, Redlands, CA). The Human Investigation Committee at the Yale School of Medicine approved an exemption for the authors to use CMS claims and enrollment data for research analyses and publication.
Results
Hospital‐Specific Risk‐Standardized 30‐Day Mortality and Readmission Rates
Of the 1,118,583 patients included in the mortality analysis 129,444 (11.6%) died within 30 days of hospital admission. The median (Q1, Q3) hospital 30‐day risk‐standardized mortality rate was 11.1% (10.0%, 12.3%), and ranged from 6.7% to 20.9% (Table 1, Figure 1). Hospitals at the 10th percentile had 30‐day risk‐standardized mortality rates of 9.0% while for those at the 90th percentile of performance the rate was 13.5%. The odds of all‐cause mortality for a patient treated at a hospital that was one standard deviation above the national average was 1.68 times higher than that of a patient treated at a hospital that was one standard deviation below the national average.
Mortality | Readmission | |
---|---|---|
| ||
Patients (n) | 1118583 | 1161817 |
Hospitals (n) | 4788 | 4813 |
Patient age, years, median (Q1, Q3) | 81 (74,86) | 80 (74,86) |
Nonwhite, % | 11.1 | 11.1 |
Hospital case volume, median (Q1, Q3) | 168 (77,323) | 174 (79,334) |
Risk‐standardized hospital rate, mean (SD) | 11.2 (1.2) | 18.3 (0.9) |
Minimum | 6.7 | 13.6 |
1st percentile | 7.5 | 14.9 |
5th percentile | 8.5 | 15.8 |
10th percentile | 9.0 | 16.4 |
25th percentile | 10.0 | 17.2 |
Median | 11.1 | 18.2 |
75th percentile | 12.3 | 19.2 |
90th percentile | 13.5 | 20.4 |
95th percentile | 14.4 | 21.1 |
99th percentile | 16.1 | 22.8 |
Maximum | 20.9 | 26.7 |
Model fit statistics | ||
c‐Statistic | 0.72 | 0.63 |
Intrahospital Correlation | 0.07 | 0.03 |
For the 3‐year period 2006 to 2009, 222 (4.7%) hospitals were categorized as having a mortality rate that was better than the national average, 3968 (83.7%) were no different than the national average, 221 (4.6%) were worse and 332 (7.0%) did not meet the minimum case threshold.
Among the 1,161,817 patients included in the readmission analysis 212,638 (18.3%) were readmitted within 30 days of hospital discharge. The median (Q1,Q3) 30‐day risk‐standardized readmission rate was 18.2% (17.2%, 19.2%) and ranged from 13.6% to 26.7% (Table 1, Figure 2). Hospitals at the 10th percentile had 30‐day risk‐standardized readmission rates of 16.4% while for those at the 90th percentile of performance the rate was 20.4%. The odds of all‐cause readmission for a patient treated at a hospital that was one standard deviation above the national average was 1.40 times higher than the odds of all‐cause readmission if treated at a hospital that was one standard deviation below the national average.
For the 3‐year period 2006 to 2009, 64 (1.3%) hospitals were categorized as having a readmission rate that was better than the national average, 4203 (88.2%) were no different than the national average, 163 (3.4%) were worse and 333 (7.0%) had less than 25 cases and were therefore not categorized.
While risk‐standardized readmission rates were substantially higher than risk‐standardized mortality rates, mortality rates varied more. For example, the top 10% of hospitals had a relative mortality rate that was 33% lower than those in the bottom 10%, as compared with just a 20% relative difference for readmission rates. The coefficient of variation, a normalized measure of dispersion that unlike the standard deviation is independent of the population mean, was 10.7 for risk‐standardized mortality rates and 4.9 for readmission rates.
Regional Risk‐Standardized 30‐Day Mortality and Readmission Rates
Figures 3 and 4 show the distribution of 30‐day risk‐standardized mortality and readmission rates among hospital referral regions by quintile. Highest mortality regions were found across the entire country, including parts of Northern New England, the Mid and South Atlantic, East and the West South Central, East and West North Central, and the Mountain and Pacific regions of the West. The lowest mortality rates were observed in Southern New England, parts of the Mid and South Atlantic, East and West South Central, and parts of the Mountain and Pacific regions of the West (Figure 3).
Readmission rates were higher in the eastern portions of the US (including the Northeast, Mid and South Atlantic, East South Central) as well as the East North Central, and small parts of the West North Central portions of the Midwest and in Central California. The lowest readmission rates were observed in the West (Mountain and Pacific regions), parts of the Midwest (East and West North Central) and small pockets within the South and Northeast (Figure 4).
Discussion
In this 3‐year analysis of patient, hospital, and regional outcomes we observed that pneumonia in the elderly remains a highly morbid illness, with a 30‐day mortality rate of approximately 11.6%. More notably we observed that risk‐standardized mortality rates, and to a lesser extent readmission rates, vary significantly across hospitals and regions. Finally, we observed that readmission rates, but not mortality rates, show strong geographic concentration.
These findings suggest possible opportunities to save or extend the lives of a substantial number of Americans, and to reduce the burden of rehospitalization on patients and families, if low performing institutions were able to achieve the performance of those with better outcomes. Additionally, because readmission is so common (nearly 1 in 5 patients), efforts to reduce overall health care spending should focus on this large potential source of savings.19 In this regard, impending changes in payment to hospitals around readmissions will change incentives for hospitals and physicians that may ultimately lead to lower readmission rates.20
Previous analyses of the quality of hospital care for patients with pneumonia have focused on the percentage of eligible patients who received guideline‐recommended antibiotics within a specified time frame (4 or 8 hours), and vaccination prior to hospital discharge.21, 22 These studies have highlighted large differences across hospitals and states in the percentage receiving recommended care. In contrast, the focus of this study was to compare risk‐standardized outcomes of care at the nation's hospitals and across its regions. This effort was guided by the notion that the measurement of care outcomes is an important complement to process measurement because outcomes represent a more holistic assessment of care, that an outcomes focus offers hospitals greater autonomy in terms of what processes to improve, and that outcomes are ultimately more meaningful to patients than the technical aspects of how the outcomes were achieved. In contrast to these earlier process‐oriented efforts, the magnitude of the differences we observed in mortality and readmission rates across hospitals was not nearly as large.
A recent analysis of the outcomes of care for patients with heart failure and acute myocardial infarction also found significant variation in both hospital and regional mortality and readmission rates.23 The relative differences in risk‐standardized hospital mortality rates across the 10th to 90th percentiles of hospital performance was 25% for acute myocardial infarction, and 39% for heart failure. By contrast, we found that the difference in risk‐standardized hospital mortality rates across the 10th to 90th percentiles in pneumonia was an even greater 50% (13.5% vs. 9.0%). Similar to the findings in acute myocardial infarction and heart failure, we observed that risk‐standardized mortality rates varied more so than did readmission rates.
Our study has a number of limitations. First, the analysis was restricted to Medicare patients only, and our findings may not be generalizable to younger patients. Second, our risk‐adjustment methods relied on claims data, not clinical information abstracted from charts. Nevertheless, we assessed comorbidities using all physician and hospital claims from the year prior to the index admission. Additionally our mortality and readmission models were validated against those based on medical record data and the outputs of the 2 approaches were highly correlated.15, 24, 25 Our study was restricted to patients with a principal diagnosis of pneumonia, and we therefore did not include those whose principal diagnosis was sepsis or respiratory failure and who had a secondary diagnosis of pneumonia. While this decision was made to reduce the risk of misclassifying complications of care as the reason for admission, we acknowledge that this is likely to have limited our study to patients with less severe disease, and may have introduced bias related to differences in hospital coding practices regarding the use of sepsis and respiratory failure codes. While we excluded patients with 1 day length of stay from the mortality analysis to reduce the risk of including patients in the measure who did not actually have pneumonia, we did not exclude them from the readmission analysis because very short length of stay may be a risk factor for readmission. An additional limitation of our study is that our findings are primarily descriptive, and we did not attempt to explain the sources of the variation we observed. For example, we did not examine the extent to which these differences might be explained by differences in adherence to process measures across hospitals or regions. However, if the experience in acute myocardial infarction can serve as a guide, then it is unlikely that more than a small fraction of the observed variation in outcomes can be attributed to factors such as antibiotic timing or selection.26 Additionally, we cannot explain why readmission rates were more geographically distributed than mortality rates, however it is possible that this may be related to the supply of physicians or hospital beds.27 Finally, some have argued that mortality and readmission rates do not necessarily reflect the very quality they intend to measure.2830
The outcomes of patients with pneumonia appear to be significantly influenced by both the hospital and region where they receive care. Efforts to improve population level outcomes might be informed by studying the practices of hospitals and regions that consistently achieve high levels of performance.31
Acknowledgements
The authors thank Sandi Nelson, Eric Schone, and Marian Wrobel at Mathematicia Policy Research and Changquin Wang and Jinghong Gao at YNHHS/Yale CORE for analytic support. They also acknowledge Shantal Savage, Kanchana Bhat, and Mayur M. Desai at Yale, Joseph S. Ross at the Mount Sinai School of Medicine, and Shaheen Halim at the Centers for Medicare and Medicaid Services.
Pneumonia results in some 1.2 million hospital admissions each year in the United States, is the second leading cause of hospitalization among patients over 65, and accounts for more than $10 billion annually in hospital expenditures.1, 2 As a result of complex demographic and clinical forces, including an aging population, increasing prevalence of comorbidities, and changes in antimicrobial resistance patterns, between the periods 1988 to 1990 and 2000 to 2002 the number of patients hospitalized for pneumonia grew by 20%, and pneumonia was the leading infectious cause of death.3, 4
Given its public health significance, pneumonia has been the subject of intensive quality measurement and improvement efforts for well over a decade. Two of the largest initiatives are the Centers for Medicare & Medicaid Services (CMS) National Pneumonia Project and The Joint Commission ORYX program.5, 6 These efforts have largely entailed measuring hospital performance on pneumonia‐specific processes of care, such as whether blood oxygen levels were assessed, whether blood cultures were drawn before antibiotic treatment was initiated, the choice and timing of antibiotics, and smoking cessation counseling and vaccination at the time of discharge. While measuring processes of care (especially when they are based on sound evidence), can provide insights about quality, and can help guide hospital improvement efforts, these measures necessarily focus on a narrow spectrum of the overall care provided. Outcomes can complement process measures by directing attention to the results of care, which are influenced by both measured and unmeasured factors, and which may be more relevant from the patient's perspective.79
In 2008 CMS expanded its public reporting initiatives by adding risk‐standardized hospital mortality rates for pneumonia to the Hospital Compare website (
Methods
Design, Setting, Subjects
We conducted a cross‐sectional study at the hospital level of the outcomes of care of fee‐for‐service patients hospitalized for pneumonia between July 2006 and June 2009. Patients are eligible to be included in the measures if they are 65 years or older, have a principal diagnosis of pneumonia (International Classification of Diseases, Ninth Revision, Clinical Modification codes 480.X, 481, 482.XX, 483.X, 485, 486, and 487.0), and are cared for at a nonfederal acute care hospital in the US and its organized territories, including Puerto Rico, Guam, the US Virgin Islands, and the Northern Mariana Islands.
The mortality measure excludes patients enrolled in the Medicare hospice program in the year prior to, or on the day of admission, those in whom pneumonia is listed as a secondary diagnosis (to eliminate cases resulting from complications of hospitalization), those discharged against medical advice, and patients who are discharged alive but whose length of stay in the hospital is less than 1 day (because of concerns about the accuracy of the pneumonia diagnosis). Patients are also excluded if their administrative records for the period of analysis (1 year prior to hospitalization and 30 days following discharge) were not available or were incomplete, because these are needed to assess comorbid illness and outcomes. The readmission measure is similar, but does not exclude patients on the basis of hospice program enrollment (because these patients have been admitted and readmissions for hospice patients are likely unplanned events that can be measured and reduced), nor on the basis of hospital length of stay (because patients discharged within 24 hours may be at a heightened risk of readmission).11, 12
Information about patient comorbidities is derived from diagnoses recorded in the year prior to the index hospitalization as found in Medicare inpatient, outpatient, and carrier (physician) standard analytic files. Comorbidities are identified using the Condition Categories of the Hierarchical Condition Category grouper, which sorts the more than 15,000 possible diagnostic codes into 189 clinically‐coherent conditions and which was originally developed to support risk‐adjusted payments within Medicare managed care.13
Outcomes
The patient outcomes assessed include death from any cause within 30 days of admission and readmission for any cause within 30 days of discharge. All‐cause, rather than disease‐specific, readmission was chosen because hospital readmission as a consequence of suboptimal inpatient care or discharge coordination may manifest in many different diagnoses, and no validated method is available to distinguish related from unrelated readmissions. The measures use the Medicare Enrollment Database to determine mortality status, and acute care hospital inpatient claims are used to identify readmission events. For patients with multiple hospitalizations during the study period, the mortality measure randomly selects one hospitalization to use for determination of mortality. Admissions that are counted as readmissions (i.e., those that occurred within 30 days of discharge following hospitalization for pneumonia) are not also treated as index hospitalizations. In the case of patients who are transferred to or from another acute care facility, responsibility for deaths is assigned to the hospital that initially admitted the patient, while responsibility for readmissions is assigned to the hospital that ultimately discharges the patient to a nonacute setting (e.g., home, skilled nursing facilities).
Risk‐Standardization Methods
Hierarchical logistic regression is used to model the log‐odds of mortality or readmission within 30 days of admission or discharge from an index pneumonia admission as a function of patient demographic and clinical characteristics and a random hospital‐specific intercept. This strategy accounts for within‐hospital correlation of the observed outcomes, and reflects the assumption that underlying differences in quality among the hospitals being evaluated lead to systematic differences in outcomes. In contrast to nonhierarchical models which ignore hospital effects, this method attempts to measure the influence of the hospital on patient outcome after adjusting for patient characteristics. Comorbidities from the index admission that could represent potential complications of care are not included in the model unless they are also documented in the 12 months prior to admission. Hospital‐specific mortality and readmission rates are calculated as the ratio of predicted‐to‐expected events (similar to the observed/expected ratio), multiplied by the national unadjusted rate, a form of indirect standardization.
The model for mortality has a c‐statistic of 0.72 whereas a model based on medical record review that was developed for validation purposes had a c‐statistic of 0.77. The model for readmission has a c‐statistic of 0.63 whereas a model based on medical review had a c‐statistic of 0.59. The mortality and readmission models produce similar state‐level mortality and readmission rate estimates as the models derived from medical record review, and can therefore serve as reasonable surrogates. These methods, including their development and validation, have been described fully elsewhere,14, 15 and have been evaluated and subsequently endorsed by the National Quality Forum.16
Identification of Geographic Regions
To characterize patterns of performance geographically we identified the 306 hospital referral regions for each hospital in our analysis using definitions provided by the Dartmouth Atlas of Health Care project. Unlike a hospital‐level analysis, the hospital referral regions represent regional markets for tertiary care and are widely used to summarize variation in medical care inputs, utilization patterns, and health outcomes and provide a more detailed look at variation in outcomes than results at the state level.17
Analyses
Summary statistics were constructed using frequencies and proportions for categorical data, and means, medians and interquartile ranges for continuous variables. To characterize 30‐day risk‐standardized mortality and readmission rates at the hospital‐referral region level, we calculated means and percentiles by weighting each hospital's value by the inverse of the variance of the hospital's estimated rate. Hospitals with larger sample sizes, and therefore more precise estimates, lend more weight to the average. Hierarchical models were estimated using the SAS GLIMMIX procedure. Bayesian shrinkage was used to estimate rates in order to take into account the greater uncertainty in the true rates of hospitals with small caseloads. Using this technique, estimated rates at low volume institutions are shrunken toward the population mean, while hospitals with large caseloads have a relatively smaller amount of shrinkage and the estimate is closer to the hospital's observed rate.18
To determine whether a hospital's performance is significantly different than the national rate we measured whether the 95% interval estimate for the risk‐standardized rate overlapped with the national crude mortality or readmission rate. This information is used to categorize hospitals on Hospital Compare as better than the US national rate, worse than the US national rate, or no different than the US national rate. Hospitals with fewer than 25 cases in the 3‐year period, are excluded from this categorization on Hospital Compare.
Analyses were conducted with the use of SAS 9.1.3 (SAS Institute Inc, Cary, NC). We created the hospital referral region maps using ArcGIS version 9.3 (ESRI, Redlands, CA). The Human Investigation Committee at the Yale School of Medicine approved an exemption for the authors to use CMS claims and enrollment data for research analyses and publication.
Results
Hospital‐Specific Risk‐Standardized 30‐Day Mortality and Readmission Rates
Of the 1,118,583 patients included in the mortality analysis 129,444 (11.6%) died within 30 days of hospital admission. The median (Q1, Q3) hospital 30‐day risk‐standardized mortality rate was 11.1% (10.0%, 12.3%), and ranged from 6.7% to 20.9% (Table 1, Figure 1). Hospitals at the 10th percentile had 30‐day risk‐standardized mortality rates of 9.0% while for those at the 90th percentile of performance the rate was 13.5%. The odds of all‐cause mortality for a patient treated at a hospital that was one standard deviation above the national average was 1.68 times higher than that of a patient treated at a hospital that was one standard deviation below the national average.
Mortality | Readmission | |
---|---|---|
| ||
Patients (n) | 1118583 | 1161817 |
Hospitals (n) | 4788 | 4813 |
Patient age, years, median (Q1, Q3) | 81 (74,86) | 80 (74,86) |
Nonwhite, % | 11.1 | 11.1 |
Hospital case volume, median (Q1, Q3) | 168 (77,323) | 174 (79,334) |
Risk‐standardized hospital rate, mean (SD) | 11.2 (1.2) | 18.3 (0.9) |
Minimum | 6.7 | 13.6 |
1st percentile | 7.5 | 14.9 |
5th percentile | 8.5 | 15.8 |
10th percentile | 9.0 | 16.4 |
25th percentile | 10.0 | 17.2 |
Median | 11.1 | 18.2 |
75th percentile | 12.3 | 19.2 |
90th percentile | 13.5 | 20.4 |
95th percentile | 14.4 | 21.1 |
99th percentile | 16.1 | 22.8 |
Maximum | 20.9 | 26.7 |
Model fit statistics | ||
c‐Statistic | 0.72 | 0.63 |
Intrahospital Correlation | 0.07 | 0.03 |
For the 3‐year period 2006 to 2009, 222 (4.7%) hospitals were categorized as having a mortality rate that was better than the national average, 3968 (83.7%) were no different than the national average, 221 (4.6%) were worse and 332 (7.0%) did not meet the minimum case threshold.
Among the 1,161,817 patients included in the readmission analysis 212,638 (18.3%) were readmitted within 30 days of hospital discharge. The median (Q1,Q3) 30‐day risk‐standardized readmission rate was 18.2% (17.2%, 19.2%) and ranged from 13.6% to 26.7% (Table 1, Figure 2). Hospitals at the 10th percentile had 30‐day risk‐standardized readmission rates of 16.4% while for those at the 90th percentile of performance the rate was 20.4%. The odds of all‐cause readmission for a patient treated at a hospital that was one standard deviation above the national average was 1.40 times higher than the odds of all‐cause readmission if treated at a hospital that was one standard deviation below the national average.
For the 3‐year period 2006 to 2009, 64 (1.3%) hospitals were categorized as having a readmission rate that was better than the national average, 4203 (88.2%) were no different than the national average, 163 (3.4%) were worse and 333 (7.0%) had less than 25 cases and were therefore not categorized.
While risk‐standardized readmission rates were substantially higher than risk‐standardized mortality rates, mortality rates varied more. For example, the top 10% of hospitals had a relative mortality rate that was 33% lower than those in the bottom 10%, as compared with just a 20% relative difference for readmission rates. The coefficient of variation, a normalized measure of dispersion that unlike the standard deviation is independent of the population mean, was 10.7 for risk‐standardized mortality rates and 4.9 for readmission rates.
Regional Risk‐Standardized 30‐Day Mortality and Readmission Rates
Figures 3 and 4 show the distribution of 30‐day risk‐standardized mortality and readmission rates among hospital referral regions by quintile. Highest mortality regions were found across the entire country, including parts of Northern New England, the Mid and South Atlantic, East and the West South Central, East and West North Central, and the Mountain and Pacific regions of the West. The lowest mortality rates were observed in Southern New England, parts of the Mid and South Atlantic, East and West South Central, and parts of the Mountain and Pacific regions of the West (Figure 3).
Readmission rates were higher in the eastern portions of the US (including the Northeast, Mid and South Atlantic, East South Central) as well as the East North Central, and small parts of the West North Central portions of the Midwest and in Central California. The lowest readmission rates were observed in the West (Mountain and Pacific regions), parts of the Midwest (East and West North Central) and small pockets within the South and Northeast (Figure 4).
Discussion
In this 3‐year analysis of patient, hospital, and regional outcomes we observed that pneumonia in the elderly remains a highly morbid illness, with a 30‐day mortality rate of approximately 11.6%. More notably we observed that risk‐standardized mortality rates, and to a lesser extent readmission rates, vary significantly across hospitals and regions. Finally, we observed that readmission rates, but not mortality rates, show strong geographic concentration.
These findings suggest possible opportunities to save or extend the lives of a substantial number of Americans, and to reduce the burden of rehospitalization on patients and families, if low performing institutions were able to achieve the performance of those with better outcomes. Additionally, because readmission is so common (nearly 1 in 5 patients), efforts to reduce overall health care spending should focus on this large potential source of savings.19 In this regard, impending changes in payment to hospitals around readmissions will change incentives for hospitals and physicians that may ultimately lead to lower readmission rates.20
Previous analyses of the quality of hospital care for patients with pneumonia have focused on the percentage of eligible patients who received guideline‐recommended antibiotics within a specified time frame (4 or 8 hours), and vaccination prior to hospital discharge.21, 22 These studies have highlighted large differences across hospitals and states in the percentage receiving recommended care. In contrast, the focus of this study was to compare risk‐standardized outcomes of care at the nation's hospitals and across its regions. This effort was guided by the notion that the measurement of care outcomes is an important complement to process measurement because outcomes represent a more holistic assessment of care, that an outcomes focus offers hospitals greater autonomy in terms of what processes to improve, and that outcomes are ultimately more meaningful to patients than the technical aspects of how the outcomes were achieved. In contrast to these earlier process‐oriented efforts, the magnitude of the differences we observed in mortality and readmission rates across hospitals was not nearly as large.
A recent analysis of the outcomes of care for patients with heart failure and acute myocardial infarction also found significant variation in both hospital and regional mortality and readmission rates.23 The relative differences in risk‐standardized hospital mortality rates across the 10th to 90th percentiles of hospital performance was 25% for acute myocardial infarction, and 39% for heart failure. By contrast, we found that the difference in risk‐standardized hospital mortality rates across the 10th to 90th percentiles in pneumonia was an even greater 50% (13.5% vs. 9.0%). Similar to the findings in acute myocardial infarction and heart failure, we observed that risk‐standardized mortality rates varied more so than did readmission rates.
Our study has a number of limitations. First, the analysis was restricted to Medicare patients only, and our findings may not be generalizable to younger patients. Second, our risk‐adjustment methods relied on claims data, not clinical information abstracted from charts. Nevertheless, we assessed comorbidities using all physician and hospital claims from the year prior to the index admission. Additionally our mortality and readmission models were validated against those based on medical record data and the outputs of the 2 approaches were highly correlated.15, 24, 25 Our study was restricted to patients with a principal diagnosis of pneumonia, and we therefore did not include those whose principal diagnosis was sepsis or respiratory failure and who had a secondary diagnosis of pneumonia. While this decision was made to reduce the risk of misclassifying complications of care as the reason for admission, we acknowledge that this is likely to have limited our study to patients with less severe disease, and may have introduced bias related to differences in hospital coding practices regarding the use of sepsis and respiratory failure codes. While we excluded patients with 1 day length of stay from the mortality analysis to reduce the risk of including patients in the measure who did not actually have pneumonia, we did not exclude them from the readmission analysis because very short length of stay may be a risk factor for readmission. An additional limitation of our study is that our findings are primarily descriptive, and we did not attempt to explain the sources of the variation we observed. For example, we did not examine the extent to which these differences might be explained by differences in adherence to process measures across hospitals or regions. However, if the experience in acute myocardial infarction can serve as a guide, then it is unlikely that more than a small fraction of the observed variation in outcomes can be attributed to factors such as antibiotic timing or selection.26 Additionally, we cannot explain why readmission rates were more geographically distributed than mortality rates, however it is possible that this may be related to the supply of physicians or hospital beds.27 Finally, some have argued that mortality and readmission rates do not necessarily reflect the very quality they intend to measure.2830
The outcomes of patients with pneumonia appear to be significantly influenced by both the hospital and region where they receive care. Efforts to improve population level outcomes might be informed by studying the practices of hospitals and regions that consistently achieve high levels of performance.31
Acknowledgements
The authors thank Sandi Nelson, Eric Schone, and Marian Wrobel at Mathematicia Policy Research and Changquin Wang and Jinghong Gao at YNHHS/Yale CORE for analytic support. They also acknowledge Shantal Savage, Kanchana Bhat, and Mayur M. Desai at Yale, Joseph S. Ross at the Mount Sinai School of Medicine, and Shaheen Halim at the Centers for Medicare and Medicaid Services.
- http://www.hcup‐us.ahrq.gov/reports.jsp. Accessed June2010. , , , , . HCUP Facts and Figures: Statistics on Hospital‐based Care in the United States, 2007 [Internet]. 2009 [cited 2009 Nov 7]. Available at:
- Agency for Healthcare Research and Quality. HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). [Internet]. 2007 [cited 2010 May 13]. Available at: http://www.hcup‐us.ahrq.gov/nisoverview.jsp. Accessed June2010.
- Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988‐2002.JAMA.20057;294(21):2712–2719. , , , , .
- http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_ 14.pdf. Accessed June2010. . Deaths: Leading Causes for 2006. NVSS [Internet]. 2010 Mar 31;58(14). Available at:
- Centers for Medicare and Medicaid Services. Pneumonia [Internet]. [cited 2010 May 13]. Available at: http://www.qualitynet.org/dcs/ContentServer?cid= 108981596702326(1):75–85.
- Performance measures for pneumonia: are they valuable, and are process measures adequate?Curr Opin Infect Dis.2007;20(2):182–189. , , .
- Relationship Between Medicare's Hospital Compare Performance Measures and Mortality Rates.JAMA.2006;296(22):2694–2702. , .
- Medicare.gov ‐ Hospital Compare [Internet]. [cited 2009 Nov 6]. Available at: http://www.hospitalcompare.hhs.gov/Hospital/Search/Welcome.asp? version=default 2010. Available at: http://www.qualitynet.org/dcs/ContentServer? c=Page 2010. Available at: http://www.qualitynet.org/dcs/ContentServer? c=Page 2000 [cited 2009 Nov 7]. Available at: http://www.cms.hhs.gov/Reports/Reports/ItemDetail.asp?ItemID=CMS023176. Accessed June2010.
- http://www.qualitynet.org/dcs/ContentServer?c= Page 2008. Available at: http://www.qualitynet.org/dcs/ContentServer?c= Page1999. , , , et al. Risk‐Adjustment Methodology for Hospital Monitoring/Surveillance and Public Reporting Supplement #1: 30‐Day Mortality Model for Pneumonia [Internet]. Yale University; 2006. Available at:
- Statistical and clinical aspects of hospital outcomes profiling.Stat Sci.2007;22(2):206–226. , .
- Medicare Payment Advisory Commission. Report to the Congress: Promoting Greater Efficiency in Medicare.2007 June.
- Patient Protection and Affordable Care Act [Internet]. 2010. Available at: http://thomas.loc.gov. Accessed June2010.
- Quality of medical care delivered to medicare beneficiaries: a profile at state and national levels.JAMA.2000;284(13):1670–1676. , , , et al.
- Care in U.S. hospitals — the hospital quality alliance program.N Engl J Med.2005;353(3):265–274. , , , .
- Patterns of hospital performance in acute myocardial infarction and heart failure 30‐day mortality and readmission.Circ Cardiovasc Qual Outcomes.2009;2(5):407–413. , , , et al.
- An administrative claims model suitable for profiling hospital performance based on 30‐day mortality rates among patients with heart failure.Circulation.2006;113(13):1693–1701. , , , et al.
- An administrative claims model suitable for profiling hospital performance based on 30‐day mortality rates among patients with an acute myocardial infarction.Circulation.2006;113(13):1683–1692. , , , et al.
- Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short‐term mortality.JAMA.2006;296(1):72–78. , , , et al.
- Hospital readmission rates for cohorts of medicare beneficiaries in Boston and New Haven.N Engl J Med.1994;331(15):989–995. , , , .
- Research evidence on the validity of risk‐adjusted mortality rate as a measure of hospital quality of care.Med Care Res Rev.1998;55(4):371–404. , .
- Hospital readmissions as a measure of quality of health care: advantages and limitations.Arch Intern Med.2000;160(8):1074–1081. , .
- Hospital mortality: when failure is not a good measure of success.CMAJ.2008;179(2):153–157. , .
- Research in action: using positive deviance to improve quality of health care.Implement Sci.2009;4:25. , , , , , .
- http://www.hcup‐us.ahrq.gov/reports.jsp. Accessed June2010. , , , , . HCUP Facts and Figures: Statistics on Hospital‐based Care in the United States, 2007 [Internet]. 2009 [cited 2009 Nov 7]. Available at:
- Agency for Healthcare Research and Quality. HCUP Nationwide Inpatient Sample (NIS). Healthcare Cost and Utilization Project (HCUP). [Internet]. 2007 [cited 2010 May 13]. Available at: http://www.hcup‐us.ahrq.gov/nisoverview.jsp. Accessed June2010.
- Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988‐2002.JAMA.20057;294(21):2712–2719. , , , , .
- http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_ 14.pdf. Accessed June2010. . Deaths: Leading Causes for 2006. NVSS [Internet]. 2010 Mar 31;58(14). Available at:
- Centers for Medicare and Medicaid Services. Pneumonia [Internet]. [cited 2010 May 13]. Available at: http://www.qualitynet.org/dcs/ContentServer?cid= 108981596702326(1):75–85.
- Performance measures for pneumonia: are they valuable, and are process measures adequate?Curr Opin Infect Dis.2007;20(2):182–189. , , .
- Relationship Between Medicare's Hospital Compare Performance Measures and Mortality Rates.JAMA.2006;296(22):2694–2702. , .
- Medicare.gov ‐ Hospital Compare [Internet]. [cited 2009 Nov 6]. Available at: http://www.hospitalcompare.hhs.gov/Hospital/Search/Welcome.asp? version=default 2010. Available at: http://www.qualitynet.org/dcs/ContentServer? c=Page 2010. Available at: http://www.qualitynet.org/dcs/ContentServer? c=Page 2000 [cited 2009 Nov 7]. Available at: http://www.cms.hhs.gov/Reports/Reports/ItemDetail.asp?ItemID=CMS023176. Accessed June2010.
- http://www.qualitynet.org/dcs/ContentServer?c= Page 2008. Available at: http://www.qualitynet.org/dcs/ContentServer?c= Page1999. , , , et al. Risk‐Adjustment Methodology for Hospital Monitoring/Surveillance and Public Reporting Supplement #1: 30‐Day Mortality Model for Pneumonia [Internet]. Yale University; 2006. Available at:
- Statistical and clinical aspects of hospital outcomes profiling.Stat Sci.2007;22(2):206–226. , .
- Medicare Payment Advisory Commission. Report to the Congress: Promoting Greater Efficiency in Medicare.2007 June.
- Patient Protection and Affordable Care Act [Internet]. 2010. Available at: http://thomas.loc.gov. Accessed June2010.
- Quality of medical care delivered to medicare beneficiaries: a profile at state and national levels.JAMA.2000;284(13):1670–1676. , , , et al.
- Care in U.S. hospitals — the hospital quality alliance program.N Engl J Med.2005;353(3):265–274. , , , .
- Patterns of hospital performance in acute myocardial infarction and heart failure 30‐day mortality and readmission.Circ Cardiovasc Qual Outcomes.2009;2(5):407–413. , , , et al.
- An administrative claims model suitable for profiling hospital performance based on 30‐day mortality rates among patients with heart failure.Circulation.2006;113(13):1693–1701. , , , et al.
- An administrative claims model suitable for profiling hospital performance based on 30‐day mortality rates among patients with an acute myocardial infarction.Circulation.2006;113(13):1683–1692. , , , et al.
- Hospital quality for acute myocardial infarction: correlation among process measures and relationship with short‐term mortality.JAMA.2006;296(1):72–78. , , , et al.
- Hospital readmission rates for cohorts of medicare beneficiaries in Boston and New Haven.N Engl J Med.1994;331(15):989–995. , , , .
- Research evidence on the validity of risk‐adjusted mortality rate as a measure of hospital quality of care.Med Care Res Rev.1998;55(4):371–404. , .
- Hospital readmissions as a measure of quality of health care: advantages and limitations.Arch Intern Med.2000;160(8):1074–1081. , .
- Hospital mortality: when failure is not a good measure of success.CMAJ.2008;179(2):153–157. , .
- Research in action: using positive deviance to improve quality of health care.Implement Sci.2009;4:25. , , , , , .
Copyright © 2010 Society of Hospital Medicine